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Indole-3-carbinol (13C), the most abundant metabolite of glucobrassicins, is
found in cruciferous vegetables such as broccoli, Brussels sprouts, cabbage and
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P4501A) and inhibits FMO1 (flavin-containing monooxygenase form 1) expression
in rat liver and intestine. We also showed that 13C induced hepatic CYP 1 Al /1 A2 in
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Redacted for Privacysimultaneous induction of CYP and repression of FMO may alter the metabolism,
disposition and toxicity of drugs andlor xenobiotics that are substrates of both
monooxygenases such as N, N-dimethylaniline, nicotine and tamoxifen.In liver
micro somes from rats fed 13C or DIM, the ratio of FMO to CYP metabolites of the
three chosen compounds decreased, mostly due to a reduction of N-oxide FMO-
dependent formation.Major concerns associated with human dietary 13C
supplementation are its estrogenic effect as seen in trout and its ability to induce
cytochrome P45 Os involved in bioactivation. Evidence presented here also
demonstrated a dose response of vitellogenin induction after 2 weeks of dietary 13C
or DIM in rainbow trout.In immature female rat, 13C and DIM significantly
induced uterine peroxidase, hepatic CYP1A1/1A2 and CYP2B1/2B2.All our
results suggested that 13C andlor DIM, in combination with other drugs that are
substrates for both monooxygenases, could alter the therapeutic effects or toxicity
of drugs.Also the estrogenic activity in rainbow trout and immature female rat
should be considered when assessing risk for the use of 13C and DIM as
chemopreventive agents or dietary supplements.©Copyright by Sirinmas Katchamart
January 3, 2000
All Rights ReservedINDOLE-3 -CARBINOL AND 3,3' -DIINDOLYLMETHANE: RELATIVE
POTENCY AS MODULATORS OF DRUG METABOLISM AND
CARCINOGENESIS
by
Sirinmas Katchamart
A THESIS
Submitted to
Oregon State University
in partial fulfillment of
the requirements for the
degree of
Doctor of Philosophy
Completed January 3, 2000
Commencement June, 2000Doctor of Philosophy thesis of Sirinmas Katchamart presented on January 3. 2000
APPROVED:
Major Professor, representing Toxicology
Chair of Department of Environmental and Molecular Toxicology
Dean of Othduate School
I understand that my thesis will become part of the permanent collection of Oregon
State University libraries. My signature below authorizes release of my thesis to
any reader upon request.
Sirinmas Katchamart, Author
Redacted for Privacy
Redacted for Privacy
Redacted for Privacy
Redacted for PrivacyACKNOWLEDGMENTS
I owe a debt of gratitude to numerous individuals whowere encouraging
and helpful in many ways during the course of graduate studies.Special thanks
goes to Dr. David E. Williams, my advisor.I very much appreciate his guidance,
patience and financial support. Thanks to Drs. Donald Reed, George Bailey,Mark
Christensen and Wilbert Gamble for being my graduate committee and the staffsof
the Laboratory Animal Resources and Food Toxicology and NutritionalLaboratory
for their assistance taking care of my animals. Thanks alsoto following people
who encouraged me:Dr.Viravan Prapapanich and her mother, Nupan
Kheaomaingam,Dr.NantanaJiramongkulandAreeWangmaneerath.
Additionally, I appreciate Sandy Segna for her expert editorial assistanceand
Angsana Phoosuntisumpunth, Dr. Siriporn Pipatsatayanuwong, Dr. Mei-FeiYueh,
Marilyn Henderson, Jin-Young Choi, Dr. Gayle Orner, Dr. DavidCarlson, Adam
Shilling, Dustin Leibelt, and Margaret Pratt for their friendship.Finally, I'm
grateful for my family in Thailand includingmy sister and her husband in Colorado
for unlimited support, Department of Medical Sciences; PublicHealth Ministry and
Royal Thai Embassy for the opportunity to study by their financialsupport.CONTRIBUTION OF AUTHORS
Dr. David Williams was involved in experimental design, the choice of
analytical methods and in the preparation of all manuscripts. He also performed N,
N dimethylaniline N-oxygention and nicotine metabolism in Chapter 3 and assisted
with the tail flick assay in Chapter 4. Drs. David Kupfer, David Stresser and
Shangara Dehal conducted the tamoxifen metabolism in chapter 3.Dr. Paul
Franklin provided instrumentation and instruction for the tail flick assay in Chapter
4. Dr. Cliff Pereira was responsible in statistical analysis in Chapter 4. Dr. David
Carison and Adam Shilling assisted with taking blood in trout and the vitellogenin
analysis in chapter 5. Dr. Mei-Fei Yueh assisted with animal care and necropsy.TABLE OF CONTENTS
Pagç
CHAPTER 1: INTRODUCTION----------------------------------------------- 1
Occurrence of Indole-3-Carbinol (13C) and 3,3'-
Diindolylmethane--------------------------------------2
Postulated Mechanism of Anticarcinogenic
Activities-------------------------------------------------4
Endocrine Effects---------------------------------------12
Other Biological Properties---------------------------17
Tumor Promotion and Enhancement----------------17
Other Toxicities----------------------------------------18
Summary ------------------------------------------------21
References----------------------------------------------23
CHAPTER 2: SPECIES-SPECIFIC VARIATIONS iN DIETARY INDOLE-3-
CARBINOL INHIBITION OF FLAVIN-CONTAINING
MONOOXYGENASE FORM 1 EXPRESSION IN
GUINEA PIG, MICE AND RABBIT LIVER---------------40
Abstract---------------------------------------------------41
Introduction----------------------------------------------42
Materials and Methods---------------------------------44
Results----------------------------------------------------46
Discussion------------------------------------------------48
References------------------------------------------------50TABLE OF CONTENTS (Continued)
CHAPTER 3: INHIBITION OF FMO PROTEIN EXPRESSION AND FMO-
MEDIATED TAMOXIFEN METABOLISM BY DIETARY
INDOLE-3-CARBINOL AND 3,3'-DIINDOLYLMETHANE
IN THE RAT -----------------------------------------------------53
Abstract ---------------------------------------------------54
Introduction ----------------------------------------------55
Materials and Methods ---------------------------------57
Results ----------------------------------------------------60
Discussion ------------------------------------------------66
References ------------------------------------------------72
CHAPTER 4: INHIBITION OF FMO-MEDIATED CODEINE
ANALGESIA BY DIETARY INDOLE-3-CARBINOL
AND 3,3'DIINDOLYLMETHANE IN THE RAT ----------78
Abstract --------------------------------------------------79
Introduction ---------------------------------------------80
Materials and Methods --------------------------------81
Results ---------------------------------------------------84
Discussion -----------------------------------------------89
References -----------------------------------------------92TABLE OF CONTENTS (Continued)
Page
CHAPTER 5: IN VIVO ESTROGENIC ACTIVIY OF INDOLE-3-
CARBINOL AND 3,3'-DIINDOLYLMETHANE
IN RAINBOW TROUT AND IMMATURE
FEMALE RAT ---------------------------------------------------- 97
Abstract --------------------------------------------------- 98
Introduction ----------------------------------------------99
Materials and Methods ---------------------------------101
Results ----------------------------------------------------104
Discussion ------------------------------------------------113
References ------------------------------------------------115
CHAPTERS: CONCLUSIONS --------------------------------------------------118
Summary -------------------------------------------------- 119
References ------------------------------------------------121
BIBLIOGRAPHY ------------------------------------------------------------------122LIST OF FIGURES
Figure gç
1.1Enzymatic hydrolysis of glucobrassicin, found in cruciferous
vegetables, and formation of 13C--------------------------------------3
1.2Structure of 13C acid condensation products found in liver
extracts of rats given 13C orally ----------------------------------------11
2.1Western blots of hepatic microsomal protein probed with
antibody to CYP1A1/1A2----------------------------------------------46
2.2Western blots of hepatic microsomal protein probed with
antibody to FMO1-------------------------------------------------------47
3.1Western blotting analysis of FMO 1 protein levels in liver
microsomes from rats treated with 13C or DIM at doses of 1000
and 2500 ppm for 4 weeks---------------------------------------------62
3.2FMO-dependent N-oxygenation (solid bars) and CYP-dependent
N-demethylation (striped bars) of N, N-dimethylaniline (DMA)
in liver microsomes from rats treated with 13C or DIM at doses of
1000 and 2500 ppm for 4 weeks---------------------------------------63
3.3CYP-and FMO-mediatated metabolism of 3H-(S)-nicotine--------64
3.4FMO-mediated TAM N-oxide (solid bars) and CYP-mediated
4-hydroxy TAM and N-desmethyl TAM (striped bars) formation
by liver microsomes from rats treated with 13C or DIM at doses
of 1000 and 2500 ppm for 4 weeks------------------------------------65
4.1The analgesic response for codeine administration to 13C-
pretreated rats--------------------------------------------------------------85
4.2The analgesic response for codeine administration to DIM-
pretreated rats--------------------------------------------------------------86
4.3Western blotting analysis ofFMOl protein levels in liver
microsomes from rats fed 13C or DIM at doses of 2500
ppm for 10 weeks ---------------------------------------------------------- 87LIST OF FIGURES (Continued)
Figure Eg
4.4The CYP2D1 activity as the bufuralol 1'-hydroxylation in
liver microsomes from rats fed 13C or DIM at doses of 2500
ppm for 10 weeks -------------------------------------------------------88
5.1Time-course of plasma vitellogenin after 5-20 days dietary
feeding 1000 ppm 13C (striped bars), 10 ppm tamoxifen (white bars)
and 1000 ppm 13C plus 10 ppm tamoxifen (black bars) in
rainbow trout----------------------------------------------------------- 106
5.2Dose-response of plasma vitellogenin after 2 weeks dietary
feeding 0-2000 ppm 13C in rainbow trout-----------------------------107
5.3Dose-response of plasma vitellogenin after 2 weeks dietary
feeding 0-250 ppm DIM in rainbow trout-----------------------------108
5.4Dose-response of uterine peroxidase activity in the immature
female Sprague-Dawley rat after 5 days dietary feeding 0-2000
ppm13C --------------------------------------------------------------------109
5.5Dose-response of uterine peroxidase activity in the immature
female Sprague-Dawley rat after 5 days dietary feeding 0-250
ppmDIM -------------------------------------------------------------------110
5.6Dose-response of CYP1AI/1A2 (striped bars), CYP2B1!2B2
(white bars) and CYP3A2 (black bars) after 5 days dietary feeding
0-2000 ppm 13C in immature female rat------------------------------ill
5.7Dose-response of CYPIAI/1A2 (striped bars), CYP2B1/2B2
(white bars) and CYP3A2 (black bars) after 5 days dietary feeding
0-250 ppm DIM in immature female rat-------------------------------- 112This thesis is dedicated to my family:
Paiboon, Chutharath, Sunisa, Wanratchada and AkarapongINDOLE-3-CARBINOL AND 3,3'-DIINDOLYLMETHANE: RELATIVE
POTENCY AS MODULATORS OF DRUG METABOLISM AND
CARCINOGENESIS.
Chapter 1
INTRODUCTION
Most cancers are caused by the interaction between genetics and the
environment (Doll, 1996; Perera, 1996).Epidemiological studies show that
approximately 80% of human cancer can be attributed to tobacco smokes and diet
(Harris, 1991; ACS, 1995). Other factors are intense sun exposure, consumption of
alcohol, chronic infections (Helbocket al.,1998) and life-style influences such as
lack of exercise, obesity and reproductive history (Hendersonet al.,1991;
Feigelson and Henderson, 1996; Anderssonet al.,1997).Genetic factors are
thought to explain only about 5% of all cancers (Knudson, 1985; Venitt, 1994).
Given these observations, the majority of cancers are theoretically preventable. The
approaches to cancer prevention including the following three steps. 1) First,
reduce human exposure to environmental carcinogens through careful monitoring
of the workplace and through educational approaches to encourage changes in
lifestyle, 2) Second, identify individuals at high risk forcancer development
through predisposing genetic or biochemical factors, and 3) Third, provide
chemoprevention by dietary or synthetic substances (Stoneret al.,1997).2
Consumption of adequate fruits and vegetables is associated with a lower
risk of degenerative diseases including cancer, cardiovascular disease, cataracts and
brain dysfunction (Helbocket al.,1998). Epidemiological studies also show the
association between lack of adequate consumption of fruits and vegetables and
cancer incidence (Blocket al.,1992; Steinmetz and Potter, 1996). A low intake of
fruits and vegetables is associated with twice the cancer rate for lung, larynx, oral
cavity, esophagus, stomach, colon, rectum, bladder, pancreas, cervix and ovary
(Blocket al.,1992). There are many potential anticarcinogenic substances in fruits
and vegetables. Some of the substances are widespread, like dietary fiber, whereas
others are limited to one type of fruit or vegetable such as indole-3-carbinol (13 C)
from cruciferous vegetables.
OCCURRENCE OF INDOLE-3-CARBINOL (13C) AND 3,3'-
DIINDOLYLMETHANE (DIM)
Glucobrassicins (indole glucosinolates) are found in high concentrations in
cruciferous vegetables such as broccoli, Brussels sprouts, cabbage and cauliflower
(Fenwicket al.,1983).At neutral pH, glucobrassicins are hydrolyzed, yielding
glucose, sulfate, 3-indolylmethyl isothiocyanate, thiocyanate ion and 13C. At a
more acidic pH (3-4), the hydrolysis products are indole-3-acetonitrile (ICA),
hydrogen sulfide and elemental sulfur (McDanellet al.,1988) (Figure 1.1). 13C and
ICA are the most abundant metabolites of glucobrassicins. 13C may undergo aN-OSO3
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Figure 1 .1 Enzymatic hydrolysis of glucobrassicin, found in cruciferous vegetables, and formation of 13C. 1
Glucobrassicin; 2 = Indole-3-acetonitrile; 3 = 3-Indolylmethyl isothiocyanate; 413C; 5 = Ascorbigen; 63,3'-
Diindolylmethane (DIM) (Taken from McDanell et al., 1988).condensation reaction to produce 3,3'-diindolylmethane (DIM) or react with
ascorbic acid to form ascorbigen. Ascorbic acid is found at high levels in crucifers.
The hydrolytic enzyme involved in glucobrassicin hydrolysis for both pH levels is
myrosinase (thioglucoside glycohydrolase EC 3:2:3:1).This enzyme is found in
the plant cell within a separate compartment from the glucobrassicin and in
intestinal microflora. When the vegetables are cooked, myrosinase is inactivated
by heat, and washed out, resulting in a 3 0-60% loss of intact glucobrassicin (de Vos
and Bliijleven, 1988).
POSTULATED MECHANISM OF ANTICARCINOGENIC ACTIVITIES
Carcinogenesisisan accumulation of alterationsin genes such as
oncogenes, tumor suppressor genes, apoptosis regulating genes and DNA repair
genes (Stanley, 1995) that regulate cellular proliferation and cell death.This
process can be influenced by nutrition through hormonal, paracrine, autocrine,
immune andmetabolicmechanismsthatmodulatecellularproliferation,
differentiation and apoptosis.Due to the slow and multistage nature of
carcinogenesis, the strategies for the nutritional modulation and chemoprevention
of cancer should focus on stopping carcinogenesis at the earliest possible point in
the pathway.
The initiation stage is characterized by the 'mutation of DNA in response to
exogenous or endogenous genotoxic agents Several chemical carcinogens are not
demonstrably genotoxic, and are called epigenetic carcinogens (Termant, 1991)5
Generally, epigenetic carcinogens require high doses and prolonged exposure to be
carcinogenic. Several mechanisms of epigenetic carcinogens have been proposed,
including mutagenic processes such as oxidative stress (Guyton and Kensler,
1993), hormonal activity (Daviset al.,1993) and increasing cell proliferation
(Tennant,1993). Genotoxicagentsformreactiveelectrophiles,either
spontaneously or from cellular metabolism, and react chemically with nucleophilic
sitesin the DNA.If specific genes regulating cellular growth, such as
protooncogenes, tumor suppressor genes, apoptosis-regulating genes, or DNA
repair, are damaged, the genetic changes such as point mutations, chromosomal
translocations, deletions and inversions will be passed to the daughter cells during
cell division, leading to a collection of cells expressing the mutant genes (Eng and
Ponder, 1993).Alteration of procarcinogenic activation, enhancing carcinogen
detoxificationenzymes (Sumiyoshi and Wargovich,1990),scavengers of
electrophiles/reactive oxygen species (Perchelletet al.,1995) and enhancing DNA
repair (Weisburgeret al.,1995; Birtet al.,1988) can modulate this early stage of
carcinogenesis.
The promotion stage is characterized by transformation of initiated cells
into a population of neoplastic cells, due to alteration in gene expression and cell
proliferation.Promoting agents are not mutagenic, but rather they exert their
effects on gene expression through specific receptors (Pitot, 1993) and perturbation
of signal transduction pathways and cell cycle control (Fischer and DiGiovanni,
1995). The cell number homeostasis controlled by mitosis and apoptosis, is alteredduring the promotion stage, resulting in increased proliferation and decreased
apoptosis (Thompsonet al.,1992).Promoting agents can elicit the release and
metabolism of arachidonic acid to a series of metabolites referred to as eicosanoids.
Eicosanoids, including the prostaglandins and hydroperoxy forms of arachidonic
acid, are involved in the inflammatory process, the immune response, tissue repair
and cell proliferation (Fischer, 1995).Eicosanoids also affect several parameters
associated with cell proliferation (Liuetal.,1991). Modulation of tumor promotion
can involve signal transduction pathways, cell cycle control, apoptosis and
inflammatory processes.
The progression stage is characterized by the transformation of neoplastic
cells to an invasive malignant cell mass, resulting from additional genetic
alterations. Mutation in tumor suppressor gene p53 is frequently observed at this
stage (Harris, 1993). The p53 gene product is a transcription factor that regulates
the expression of a number of DNA-damage, cell-cycle and apoptosis-regulating
genes. Genomic stability, which is regulated by p53, and cell homeostasis are lost
during malignant progression (Livingstoneet al.,1992). DNA hypomethylation
also contributes to this stage (Guinn and Mills, 1997). Thus, p53, other cell cycle
and apoptotic regulators, as well as other genes regulating genomic instability and
DNA methylation,arecriticaltargets to prevent the progression stage of
carcinogenesis.
Epidemiological and animal studies demonstrate the protective effect
against carcinogenesis of greater fruit and vegetable consumption (Steinmetz and7
Potter, 1996). Cruciferous vegetables are unique in their high contents of 13C. 13C
has been shown to have anticarcinogenicactivity against many chemical
carcinogens such as aflatoxin Bi (AFB1) (Fong et al., 1990), 2-amino-N-methyl-5-
phenylimidazopyridine (Ph1P) and 2-amino-3-methylimidazo[4,5-J]quinoline (IQ)
(Guo et al., 1995; Xu et al., 1996), nitroazarene-1-oxide (Tanaka et al., 1992),
dimethylnitrosamine(ShertzerandTabor,1988),and7,12-
dimethylbenz[ajanthracene (DMBA) (Hendricks et al., 1994). Several studies have
shown that 13C lowered cancer incidences in many target organs including
endometrium (Kojima et al., 1994), forestomach (Wattenberg and Loub, 1978),
larynx (Newfield et al., 1993), lung (Morse et al., 1988; 1990), liver (Dashwood et
al., 1988; Morse et al., 1988; Dashwood et al., 1989; Bailey et al., 1996; Oganesian
et al., 1997), mammary (Grubbs et al., 1995), nasal mucosa (Morse et al., 1990),
stomach (Hendricks et al., 1994), swim bladder (Hendrick et al., 1994) and tongue
(Tanaka et al., 1992) in animal models.
The anticarcinogenic activity of 13C has been hypothesized to be the result
of modulation of the metabolism of procarcinogens and prevention of formation of
electrophilic intermediates, through alteration of biotransformation enzymes.
Stresser et al.(1 994a) found that after rats were given diets containing 13C,
CYP1A and CYP3A were induced in liver, resulting in increased formation of
AFM 1 and AFQ1, detoxification products of AFB 1.However, in rainbow trout,
1000 ppm 13C inhibits AFB 1-DNA adduction without sustained CYP1A induction
(Takahashi et al., 1995).Phase II biotransformation reactions include glucuronidation, sulfation,
acetylation, methylation, conjugation with glutathione (mercapturic acid synthesis)
and conjugation with amino acids such as glycine, taurine and glutamic acid. Phase
II enzymes increase the xenobiotic hydrophilicity by adding these endogenous
groups to xenobiotics, thereby promoting excretion (with the exception of
methylation and acetylation) (Timbrell, 1992).Therefore, induction of phase II
enzymes is involved in detoxification of activated procarcinogens, preventing their
binding to DNA and enhancing excretion.Studies have shown that 13C induces
Phase II enzymes including UDP-glucuronosyl transferase (Jorgenet al.,1989;
Shertzer and Sainsbury, 1991a; b), glutathione transferase (Sparminet al.,1982;
Shertzer and Sainsbury, 199la; b; Dangeret al.,1992; Stresseret al.,1994b),
epoxide hydrolase (Chaet al.,1985) and quinone reductase (Salbe and Bjeldanes,
1986; de Kruifet al.,1991; Shertzer and Sainsbury, 1991a; b; Wortelboeret al.,
1992a; b). The efficiency with which phase II enzymes detoxify carcinogens isa
critical factor in detennining the carcinogenicity of particular xenobiotics.
Most carcinogens damage DNA through electrophilic intermediates (Miller
and Miller, 1981).The electrophilic metabolites may themselves be reactive
oxygen species (ROS) that can directly interact with DNA. Oxygen free radicals
may also be involved in a step required for activation of a procarcinogen, thus the
reactions involved in metabolic activation of carcinogens may release ROS thatcan
in turn attack DNA (Perchelletet al.,1995). Under oxidative stress conditions,
ROS can interact with biomolecules including DNA (base modification and strandbreaks),proteins(carbonylformation,methionineorcysteineoxidation,
fragmentation) and lipids (peroxidation).Lipid peroxidation not only destroys
lipids in cell membranes and membrane integrity, it also generates endogenous
toxicants including free radicals such as alkoxyl, peroxyl radicals and electrophiles
such as 4-hydroxynonenal. These endogenous toxicants are also reactive and can
modify DNA and protein (Toyokumet al.,1994). The antioxidant and electrophilic
scavenging properties of 13C (Shertzer, 1983; 1984; Shertzeret al.,1987; 1988;
Shertzer and Tabor, 1988; Sharmaet al.,1994; Amaoet al.,1996) have been
reported. Therefore, 13C is a plausible agent for modulating this early stage of
carcinogenesis.
The eukaryotic cell cycle can be divided into four phases: G1, S, G2 and M
phases. The G1 phase is the interval between the completion of the M phase and
the beginning of the S phase. The G2 phase is the interval between the end of S
phase and the beginning of M phase. The M phase consists of mitosis (the nuclear
division) and cell division. DNA replication occurs during the S phase. Cells in G1
can also pause in their progress for extended periods and enter a specialized resting
state called G0. There is a regulatory network of growth-inhibiting and growth-
stimulating signals transduced from the extracellular environment that converge on
Gi-acting components (Sherr, 1996; Stillman, 1996).The final targets of these
growth signaling pathways are specific sets of cyclin-dependent kinase (CDK)
protein complexes. In the G1 phase, cyclins C, Dl, D2, D3 and B are necessary for
activating the Gi CDKs (CDK2, CDK4 and CDK6), while several of the small10
proteins associated with cyclin-CDK complexes (p15, p16/Ink4a, p21/Wafi/Cipi,
p27/Kipi and p57/Kip2) act as specific inhibitors of cyclin-dependent-kinase
activity (Elledge and Harper, 1994; Sherr and Robert, 1995; Gartelet al.,1996;
Alessandriniet al.,1997). There is a loss of normal cell cycle control in G1 in
mammary tumor development and differentiation (Buckleyet al.,1993; Keyomarsi
and Pardee, 1993).13C can alter the cell cycle by decreasing the expression and
activity of cyclin-dependent kinase-6 (CDK6), resulting in theG1arrest of breast
cancer cells by an estrogen receptor (ER)-independent pathway (Coveret al.,
1998).
Cells in tissues are interconnected by gap junctions, with clusters of well-
insulated cell-to-cell channels contained in specialized plasma membrane regions.
It has been proposed that the loss or alteration of gap junctional intercellular
communication (GJIC) plays an important role in the process of carcinogenesis
(Holderet al.,1993). Adhesion of tumor cells to vascular endothelium is a primary
step in the colonization of select target organs by blood-borne cancer cells (El
Sabban and Paule, 1994).Rijinkelset al.(1998) reported that 13C prevented a
decrease in intercellular communication in human colon carcinoma cell lines
caused by stearic acid. Due to the importance of GJIC in cell proliferation and
differentiation, the inhibition of GJIC may be related to the tumor promotion stage.
The anticarcinogenic activity of 13C is indirect because 13C is converted
irreversibly via acid condensation reactions to dimers, trimers, tetramers and other
condensation products (Figure 1.2). Intravenous administration of 13C, whichHI-IM
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Figure 1.2 Structure of 13C acid condensation products found in liver extracts of rats given 13C orally. 13C itself was not
detected in liver extracts. 133', 3,3 '-diindolylmethane; LT, [2-(indol-3-ylmethyl)-indol-3-yl]indol-3-ylmethane; HI-TM,
(hydroxymethyl)indolyl-3-indolylmethane; CT, 5,6,11,12,17,1 8-hexahydroclonal[ 1 ,2b:4,5-b':7,8-b] :triindole; ICZ, 3,2-b-
indolocarbazole (Taken from Stresseretal.,1995)12
bypasses the acid environment of the stomach, does not result in biological
efficiency. 3,3'-Diindolylmethane (DIM) is a primary breakdown product in vivo
after oral administration of 13C (Stresseret al.,1995) andin vitro(Spande, 1979).
DIM inhibits AFB1-DNA binding in trout (Dashwoodet al.,1994) and mammary
tumor formation in the rat (Wattenberg and Loub, 1978; Chenet al.,1998). DIM
also induces phase I and phase II enzymes such as CYP1A1, CYP1A2, and
CYP2B2 (Jellincket a!,1993) and glutathione S-transferase (Wortelboeret al.,
1992a; b). An enhancement of apoptosis is observed in human cancer cells treated
with DIM, independent of the p53 mediated apoptosis pathway (Geet al.,1996).
ENDOCRINE EFFECTS
Estradiol and estrone, endogenous estrogens, that are distributed widely in
mammalian tissues, have been shown to be oxidized by cytochrome P450 enzymes.
2-and 4-Hydroxylations of estradiol and estrone are mainly catalyzed by CYP1A2
in human liver (Yamazakiet al.,1998). In human, CYP1B1 is an extrahepatic 17-
estradiol 4-hydroxylase under the regulatory control of the AhR (Spinket al.,
1997). CYP3A4 and CYP2C9 also catalyze these reactions to lesser extents than
do CYP 1 A2 and CYP lB 1.Estradiol 1 6c-hydroxylation is catalyzed primarily by
CYP1A2 and CYP3A4, whereas estrone l6ct-hydroxylation is catalyzed solely by
CYP3A4 in human liver microsomes (Yamazakiet al.,1998). Human CYP1A2 is
expressed only in liver, but CYP3A4 is also expressed at lower concentrations in a13
number of extrahepatic tissues (Guengerich, 1995) and is the major CYP in the
intestine (Krishna and Klotz, 1994).
2-Hydroxyestradiol has little or no carcinogenic activity (Liehret al.,
1986a; Li and Li, 1987) and exhibits antiestrogenic activity based on its inhibition
ofestrogen-stimulatedMCF-7cellgrowth(Liehretal.,1986b).2-
Hydroxyestradiol and estrone can bind to the estrogen receptor but with a markedly
reduced binding affinity (Ball and Knuppen, 1980; MacLuskyet al.,1983; van
Aswegenet al.,1989; Feigelson and Henderson, 1996), resulting in weaker
hormonal potency as compared with estradiol (Martucci and Fishman, 1979; Ball
and Knuppen,1980; Fishman1981;Schutzeetal.,1993;1994). 4-
Hydroxyestradiol is a strong carcinogen in the hamster kidney (Liehret al.,1986a;
Li and Li, 1987). 16a-Hydroxyestrone is genotoxic based on the increase in
unscheduled DNA synthesis in mouse mammary epithelial cells (Telanget al.,
1992; 1993). There is a correlation between high levels of 16a-hydroxylation and
mammary tumor incidence in humans and in several strains of mice (Schneideret
al.,1982; Bradlowet al.,1985). In contrast to 2-hydroxylation of estradiol and
estrone, 4-and 1 6cx-hydroxylation estrogens can bind to the estrogen receptor with
the same affinity as estradiol, and then activate the estrogen receptor (Martucci and
Fishman, 1979; Ball and Knuppen, 1980; Fishman and Martucci, 1980; MacLusky
et al.,1983; van Asweganet al.,1989).
2- and 4-Hydroxylation metabolites can undergo metabolic redox cycling
(Liehret al.,1986a; Liehr, 1990; Liehr and Roy, 1990) and generate free radicals14
and the chemically-reactive estrogen semiquinone/quinone intermediates, resulting
in damage to DNA and other cellular constituents (Nutteret al.,1991; Han and
Liehr, 1994a; b; Cavalieriet al.,1997). 2-Hydroxylation of estradiol and estrone to
a catechol is a major metabolic pathway in the liver (Dannanet al.,1986; Kerlanet
al.,1992; Zhuet al.,1993; Sucharet al.,1995) whereas 4-hydroxylation of
estrogens to a catechol represents a major pathway in several extrahepatic target
tissues (Bui and Weisz, 1988).
2- and 4-Hydroxylated metabolites can be detoxified to O-methylated
products by catechol O-methyltransferase (COMT).However, the metabolic
clearance of 4-OH estradiol is slower than that of 2-OH estradiol.The 0-
methylation of 4-OH estradiol is inhibited by 2-OH estradiol (Royet al.,1990). It
is possible that 4-OH estradiol persists in the body and undergoes redox cycling,
resulting in increased oxidative DNA damage. Male Syrian hamster kidney, CD-i
mouse uterus and rat pituitary, the estradiol-induced tumor sites, have very high
levels of endogenous catecholamines (up to 50-fold higher than in severalnon-
target tissues in the same animal or in other strains or species). High concentration
of catecholamines in target tissues may inhibit COMT, resulting in increased tissue
concentration of 2 and 4-hydroxy metabolites and decreased 2 and 4-methoxy
metabolites (Zhu and Liehr, 1993).Earlier studies also found that stressed mice
hadanincreasedspontaneousbreastcancerincidence(Riley,1975).
Epidemiological studies have suggested that chronic stress associated withan15
increase in endogenous catecholamine levels increases the risk for breastcancer
(Cooper et al., 1989; Faragher and Cooper, 1990; Forsen, 1991).
The formation of 1 6cx-hydroxylation estrone is elevated inwomen with
breast cancer, in women at high risk of breast cancer, and in strains of mice witha
high incidence of spontaneous mammary tumors (Schneider et al., 1982; Bradlow
et al., 1985; Osborne et al, 1988). Increased 2-hydroxylation is linked to a reduced
risk of estrogen-dependent tumors, as observed in cigarette smokers (Michnoviczet
al., 1986), reduced body weight (Fishman et al., 1975), aerobic exercise (Snowet
al., 1989), thyroid supplementation (Fishman et al., 1965) and dioxinexposure
(Bertazzi et al.,1989).Several factors are known to decrease estradiol 2-
hydroxylation, including obesity (Schneider et al., 1983), high fat diets (Museyet
al., 1987), hypothyroidism (Fishman et al., 1965) and cimetidine therapy (Galbraith
and Michnovicz, 1989). To date, there areno known modulators of estradiol 16a-
hydroxylation.
Kojima etal.(1994) showed that the spontaneousoccurrences of
endometrial adenocarcinoma and preneoplastic lesionswere reduced in Donryu rats
treated with 200, 500 and 1000 ppm 13C for 660 days, compared to controls. Inan
8-month feeding study, 13C at doses of 500 and 2000ppm, significantly lowered
the incidence and multiplicity of spontaneousmammary tumors in C3H/OuJ mice
(Bradlow et al., 1991). The alteration of estrone 2-hydroxylation associatedwith
CYP1A2 in MCF-7 cells (Tiwari et al., 1994) and in humans (Michnovicz and
Bradlow, 1991; Bradlow et al., 1994; Wong et al., 1997) is possibly the mechanism16
involved in lowering the incidence of hormone-dependent cancer mediated by 13C.
13C also inhibited the growth of an estrogen-dependent human breast cancer cell
line in a manner independent of the estrogen receptor (Coveret al.,1999).
Estrogens are classified as epigenetic carcinogens and promoters based on
their hormone receptor-mediated effect on cell proliferation (Yageret al.,1991;
Yager and Zurlo, 1995). Few hepatic tumors are found in most experimental
animals after prolonged treatment with estrogens alone. However, when used in
conjunction with a known carcinogen or initiator agent such as diethylnitrosamine,
estrogens can act as a promoting agents by dramatically enhancing the effects of a
carcinogen initiator (Diwanet al.,1991).
In addition to antiestrogenic effects, 13C exhibits estrogenic activity as
shown by induction of plasma vitellogenin during 13C promotion of aflatoxin Bi-
initiated liver tumors in trout (Oganesianet al.,1999). Nunezet al.(1989) reported
that immature rainbow trout, initiated with subcarcinogenic doses of aflatoxin B 1
and fed173-estradiol, showed reduced growth and increased DNA synthesis,
mortality, and liver tumor incidence. In the C57BL/6J infant mouse model, long-
term dietary 13C inhibited diethylnitrosamine-induced tumor multiplicity.This
result is consistent with a hypothesis supporting an estrogenic mechanism of 13C,
as it is known that estrogen inhibits chemically induced liver tumors in mice (Poole
and Drinkwater, 1996).17
OTHER BIOLOGICAL PROPERTIES
Dunn and LeBlance (1994) showed that 13C and its acid condensation
products lowered serum LDLIVLDL cholesterol levels in mice, resulting from the
inhibition of acyl-CoA:cholesterol acytransferase (ACAT).This enzyme is
responsible for esterification of free cholesterol to be stored in the liver as lipid
droplets or incorporated into lipoproteins for systemic distribution.
Three 13C acid condensation products DIM, CTI (5,6,11,12,17,18-
hexahydrocyclononal(1,2-b :4,5-b':7,8-b")triindole)andBIT(2,3-bis(3-
indolylmethyl)indole) competed with vinbiastine and doxorubicin, for binding to P-
glycoprotein,resultinginincreasedcellularaccumulationofthese
chemotherapeutic agents and increased efficacy of these agentsin vitro.In nude
mice, 13C can reverse multidrug resistance in chemotherapeutic drugs to tumors
without toxicity (Christensen and LeBlanc, 1996).
TUMOR PROMOTION AND ENHANCEMENT
Although 13C has received particular interest as a possible chemopreventive
agent, several studies provide clear evidence for promotion or enhancement of
carcinogenesis by 13C. Administration of 13C during the promotion stage or post
initiation enhanced liver and thyroid gland tumors induced by diethylnitrosamine in
the rat (Kimet al.,1994; 1997), colon cancer induced by 1,2-dimethylhydrazine
(DMH) in the rat (Penceet al.,1986), liver tumors induced by AFB1 in trout(Nixon et al., 1984; Bailey et al., 1987; Dashwood et al., 1991) and by 7,12-
dimethylbenz[a]anthracene (DMBA) in trout (Hendricks et al., 1994), and ornithine
decarboxylase (ODC) activity induced by 1 2-O-tetradecanoylphorbol- 13-acetate
(TPA) in mouse skin (Birt et al., 1986). At lower dietary 13C levels, promotion of
aflatoxin B 1 -initiated hepatocarcino genesis in trout may be associated with
estrogenic activity, whereas at high 13C levels CYP1A induction may also playa
role in an additive promotional phenomenon (Oganesian et al., 1999). The time of
13C exposure is important since the previous studies showed that inhibition could
occur only when 13C is given before and/or during carcinogenic exposure.
Administration of 13C after carcinogenic exposure can promote tumor formation.
However, recently a study showed that infant mice exposed to 13C through
lactationexhibitedenhancedlivertumorigenesisafterinitiationwith
diethylnitrosamine (Oganesian, 1998).
OTHER TOXICITIES
13C was not teratogenic in rats treated subcutaneously on gestation days
eight and nine at doses of 200 or 300 mg/kg body weight. A significant decrease in
fetal weight was observed at a dose of 200 mg/kg body weight, but not ata dose of
300 mg/kg.13C has shown no effect on kidney, liver and thyroid weight of
pregnant rats (Nishie and Daxenbichler, 1980).
13 C alone was not mutagenic with or without metabolic activation in the
Ames test using Salmonella typhimurium strains TA98 and TA 100or in CHO cells19
(Reddyet al.,1983, Birtet al.,1986; Kuoet al.,1992). Studies showed that 13C
was mutagenic when cotreated with nitrites at pH 3 (TiedinkCt al.,1989; Sasagawa
and Matsushima, 1991), suggesting that under the low pH conditions in the
stomach, 13C might be indirectly involved in initiation events.
The chemoprevention Branch of the National Cancer Institute sponsored
several 13C toxicity studies, including an acute oral toxicity study in rats, and 28-
day and 90-day chronic studies in rats and dogs. The results from the acute oral
toxicity study showed anLD50estimated to be more than 2,250 mg/kg body weight.
The 28-day and 90-day studiesinrats documented toxiceffectstothe
hematopoietic system, liver, hair coat and testes at doses of 20, 60, 200, 600 and
2000 mg/kg body weight, and increases in liver weight associated with induction
of smooth endoplasmic reticulum at doses of 20 and 100 mg/kg body weight,
respectively. Diarrhea was observed in the 28-day and 90- day studies in both sexes
of dogs administered 13C at doses of 15, 50 and 150 mg/kg body weight. 13C at a
dose of 150 mg/kg body weight lowered body weight and caused anemia due to
gastrointestinal disturbances, and caused thymic atrophy in both sexes and
testicular degeneration (Kelloffet al.,1996).
In some cases, conjugation with glutathione enhances the toxicity of a
xenobiotic including dihaloalkanes (Monkset al.,1990; Dekant and Vamvakas,
1993). Twodihaloalkanesthathavereceivedparticularinterestare
dichioromethane (DCM) and dibromoethane (DBE). DCM is widely used in paint,
varnish strippers, the synthesis of plastics, the manufacture of film, and thesynthesis of pharmaceutical drugs. DBE is primarily used as a lead-scavenging
agent in anti-knock mixtures added to gasoline (Andersenet al.,1987). DCM
increases pulmonary and hepatic neoplasm incidences in female and male mice.
DBE gave positive results in carcinogenicity tests sponsored by the National
Toxicology Program (NTP, 1982; 1986). There are two major biotransformation of
dihalolkane:detoxificationandtoxificationpathways.Theoxidationof
dihaloalkaneby CYP2E1is thedetoxification pathway(NTP,1982).The
toxification pathway of both compounds is a nucleophilic substitution of thiolate
for halide that occurs in a reaction catalyzed by glutathione S-transferase, yielding
S-haloalkylglutathione conjugates which are more reactive than the parent
compound (Ahmed and Anders, 1976).S-Chloromethyl-glutathione, the DCM
intermediate,undergoesafurthernucleophilicsubstitutionwithcellular
macromoleculesincludingDNA. S-2-Bromoethylglutathione,theDBE
intermediate, rearranges to eliminate the remaining halogen atom, resulting in an
episulfonium, a strong electrophile. The class theta glutathione S-transferase Ti-i
is almost exclusively responsible for the activation of DCM, whereas other classes
of glutathione S-transferase (alpha, mu and theta Ti-i) play a role in DBE
activation (van Bladerenet al.,1980; Meyeret al.,1991; Thieret al.,1993; Hayes
and Pulford, 1995; Ploemanet al.,1997).After administration of 0.5% 13C in
control diet for 2 weeks to male rats, the hepatic GSTT1 protein was induced 6.2
fold, associated with an increase in the steady-state level of mRNA, compared with
the control rats.Hepatic CYP2Ei was unchanged by 13C (Sherrattet al.,1998).21
This study suggested that taking 13C might increase susceptibility to the neoplastic
effects of DCM and DBE.
As with the Ah receptoragonist2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD),in uteroexposure to a single dose of 13C (1.0 or 100 mg/kg) resulted in
abnormalities in the male rat offspring including decreased sperm production and
decreased transit rate of sperm (Wilkeret al.,1996).Our laboratory has
preliminary evidence that the linear trimer is the only metabolite found in the liver
of neonates and fetuses from maternal mice or rats fed 13C (Oganesian, 1998;
Larsen-Su, 1998).
SUMMARY
The anticarcinogenic activity of 13C has been investigated for many years in
an attempt to understand its anticarcinogenic mechanisms before 13C is used as a
supplement for chemoprevention. Numerous studies have provided evidence for
mechanisms of anticarcinogenic activity including inhibition of CYP bioactivation,
induction of CYP detoxification, and induction of phase IT enzymes. Electrophilic
or free radical scavenging, alteration of cell cycle via decreasing the expression and
activity of cyclin-dependent kinase-6 (CDK6), and preventing a decrease in
intercellular communication also may be important. However, the anticarcinogenic
activity of 13C is indirect since 13C is converted irreversibly to its dimer and other
condensation products under the low pH condition of the stomach.3,3'-22
Diindolylmethane(DIM),theprimarybreakdownproduct,alsoshows
anticarcinogenic activity in a manner similar to 13C.
Our laboratory has shown that 13C dramatically inhibits FMO1 and induces
CYP 1 Al expression in rat liver and intestine. 2000 ppm 13C administered to male
guinea pig, mouse and rabbit induced hepatic CYP1A1/1A2.There was no
significant difference in FMO1 between control and 13 C-treated groups of guinea
pig, mouse and rabbit (Chapter 2). The alteration of FMO and CYP-mediated drug
metabolismin vitroby 13C and DIM suggested a potential enhance therapeutic
efficacy andlor toxicity of nicotine, tamoxifen and codeineinvivo (Chapter 3-4).
In addition to antiestrogenic effects, presumably mediated by induction of
estrogen 2-hydroxylation, 13C exhibits estrogenic activity by inducing plasma
vitellogenin and uterine peroxidase activity in trout and rat, respectively (Chapter
5). These and other considerations are important when assessing risk for the use of
I3C and/or DIM as a chemopreventive agent or dietary supplement.23
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Chapter 2
SPECIES-SPECIFIC VARIATIONS IN DIETARY INDOLE-3-CARBINOL
INHIBITION OF FLAVIN-CONTAINING MONOOXYGENASE FORM 1
EXPRESSION IN GUINEAPIGSMOUSE AND RABBIT LIVER
S. Katchamart and D.E. Williams
Department of Environmental and Molecular Toxicology
Oregon State University, Corvallis, OR41
ABSTRACT
Indole-3-carbinol (13C) administered in the diet to male Fischer 344 rats has
been shown to induce hepatic levels of CYP1A1 and inhibit both the expression
and activity of FMO1.However, littleis known about the effects of 13C
administered in the diet to other common laboratory species. The purpose of this
study was to determine the effect of 13C on hepatic expression of CYP1A1/1A2
and FMO1 in guinea pig, mouse and rabbit. 13C at a dose of 2000 ppm induced
hepatic CYP1A1/1A2 in male guinea pigs, mice and rabbits, however there was no
significant difference in hepatic FMO1 protein level between control and 13C
treated groups42
INTRODUCTION
Micro somalflavin-containingmonooxygenase(FMO, BC 1.14.13.8)
catalyzes oxidative NADPH metabolism of a wide variety of soft nucleophilic
substrates containing nitrogen, sulfur, phosphorus, boron, iodine or selenium
heteroatoms (Ziegler,1993; Cashman, 1995), resulting in detoxification and
toxification(Ziegler, 1988; 1990).Based on the relationship between DNA
sequences, not on catalytic activity, FMO genes are divided into families (FMO1
through FMO5) which share 50-60% identity; orthologs have greater than 80%
identity (Hineset al.,1994; Lawtonet al.,1994).
The expression of different FMO isoforms in animals may vary in relation
to various biological or physiological factors such as tissue,sex,species,
developmental stage and nutrition. The major FMO isoform found in the liver of
all mammalian species is FMO1, except adult primates and female mice in which
FMO3 is the major isoform (Phillipset al.,1995; Fallset al.,1995). FMO1 is also
present in high amount in rabbit nasal microsomes (Shehin-Johnsonet al.,1995).
The expression of FMO 1 in liver is also sex-specific in rats and mice, being higher
in the male in rat, and the female in mouse (Cherringtonet al.,1998).Previous
studies showed that in rat testosterone and estrogen were stimulatory and inhibitory,
respectively for FMO expression (Dunnanet al.,1986), but in mice the opposite
pattern is observed (Fallet al.,1997).Interestingly, the developmental pattern
observed for mouse FMO3 was similar to human FMO3, which is found at low
levels in fetal liver and then becomes the predominant isoform in adult liver.In43
contrast, hepatic FMO1 is expressed at high levels in fetus and disappears in the
adult mouse and human (Cherrington et al., 1998).In rabbit, high levels of
progesterone and cortisol produced during pregnancy, increase the expression of
FMO1 and FMO2 in liver and lung (Leeet al.,1995). Nutritional factors also play
a role. FMO expression and activity were inhibited by diet restriction in mice and
guinea pig, ascorbic acid deficiency in guinea pig (Dixit and Roche, 1984;
Brodfuehrer and Zonnoni, 1986) and by changing from a laboratory chow to a
semi-synthetic diet in rat (Kaderliket al.,1991).
Indole-3-carbinol (13C), a major component of cruciferous vegetables, and
its acid condensation products bind to the aryl hydrocarbon receptor (AhR) and
strongly induce many Phase I and Phase II enzymes, bothin vivoandin vitro
(Bjeldenaset al.,1991; Jellincket al.,1993; Loubet al.,1975; Stresseret al.,
1995). Our laboratory has shown that indole-3-carbinol (13 C) administered in the
diet to male Fischer 344 rats inhibits both the level and catalytic activity of FMO1
protein and induces CYP1A (Larsen-Su and Williams, 1996). After consumption
300 g of cooked Brussel sprouts per day for 3 weeks, the ratio of human urinary
trimethylamine and trimethylamine N-oxide was increased 2.6-3.2 fold, suggesting
that FMO activity was decreased (Cashmanet al.,1999). However, little is known
about the effects on FMO1 of 13C administered in the diet in other species. The
purpose of this study was to address the species-specificity of dietary modulation of
FMO1 by 13C from guinea pig, mouse and rabbit.MATERIALS AND METHODS
Chemicals and Diet
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13C was purchased from Aldrich Chemical Co. (Milwaukee, WI). 13C
was incorporated into diet prepared without preservatives and just before initiation
of the experiment and stored frozen until the day before feeding. Goat anti-rabbit
CYP1A1/1A2 was from Gentest (Woburn, MA). Rabbit anti-hog liver FMO1 was
a generous gift of Dr. Daniel Ziegler, University of Texas at Austin. Rabbit anti-
goat and goat anti-rabbit secondary antibody conjugated to horseradish peroxidase
were from Bio-Rad (Richmond, CA). The chemiluminescence kit was obtained
from Amersham Corp. (Arlington Heights, IL).
Animals
Three-month-old male Hartley guinea pigs, three-month-old male CD-i
mice and four-month-old male NZW rabbits were acclimated for 7 days before
being switched to diet containing 2000 ppm 13C and fed ad libitum for 4 weeks.
The animals were euthanized and livers were removed, frozen in liquidN2and
stored at -80°C until analysis.
Microsome Preparation and ImmunodetectionofCYP1A1/1A2 and FMO1
Liver microsomes were prepared by ultracentrifugation according to
Guengerich (1989). Protein was measured by the method of Lowry et al. (1951).
The liver microsomal proteins were separated by sodium dodecyl sulfate-45
polyacrylamidegelelectrophoresis(SDS-PAGE)(Laemmli,1970)and
electrophoretically transferred to nitrocellulose membrane (Towbin et al., 1979).
The blots were incubated in 2% BSA in phosphate buffer saline (PBS), followed
with goat anti-rat CYP1A1/1A2 or rabbit anti-hog liver FMO1. After washing in
PBS-Tween 20, the blots were probed with rabbit anti-goator goat anti-rabbit
secondary antibody conjugated to horseradish peroxidase and then visualized using
a chemiluminescense kit.Quantitation was performed by densitometry, using an
HP ScanJet IIcx flatbed scanner employing NIH Image version 1.54 software
(public domain, Wayne Rasband, National Institutes of Health).
Statistical Analysis
Statistical analyses of the data were performed using Student's t-test.All
data points are the mean ± SD for four animals pergroup. The p values less than
0.05 were considered significant.DISCUSSION
In this study we have demonstrated that 13C administered in the dietto male
guinea pigs, mice and rabbitsfor 4 weeks significantly induced hepatic
CYP1A1/1A2. No CYPIA1/1A2 was detected in liver microsomes fromany
control animals. There was no statistically significant difference in FMO1 protein
levels between control and 13C-treated guinea pig, mouse and rabbit. Incontrast to
our previous laboratory result (Larsen-Su and Williams, 1996), 13C inhibited
FMO1 and induced CYP1A protein levels in rat. This study suggests that there is
no correlation or common mechanism between FMO1 inhibition and CYP1A1/1A2
induction as mediated by 13C.
FMO activity, using N, N-dimethyaniline (DMA)as the substrate, was
reduced significantly in ascorbic deficient andlor diet restricted guinea pigs
(Brodfuehrer and Zannoni, 1986). Concurrently, the physiological and nutritional
factors which determine expression of FMO in guinea pigare not known. Thus, it
will be important to investigate the mechanism by which FMO1 isregulated in
guinea pig.
Due to negative regulation by testosterone, male mice have FMO 1 levels 2-
3 times lower than the female (Duffel et al., 1981). Castrationor 17--estradiol
administration (24 .igIday for 3 weeks) can increase FMO1 mRNA expression in
male mice (Fallset al.,1997). Bradlowet al.(1991) showed that 13C lowered the
level of endogenous estrogens in female mice associated withan increase in
estradiol 2-hydroxylase, resulting in a decreased spontaneousmammary tumor49
incidence. Serum testosterone levels in male mice fed diet containing 750 ppm for
7 days were decreased to less than 25%, compared to control (Wilsonet al.,1999).
However, there was no induction of FMO1 protein expression in our study in
contrast to the castration effect.
Hormones other than sex steroid hormones have been shown to modulate
liver FMO 1.Rabbit hepatic FMO 1 protein levels increased during gestation on
days10,15, 20 and 31.Subcutaneous administration of progesterone or
dexamethasone to male rabbits increased liver FMO1 mRNA levels.However,
estradiol and aldosterone had no significant effect on FMO1 (Leeet al.,1995).
Here, we have demonstrated that 13C has no effect on rabbit hepatic FMO 1 protein.
Further studies on the regulation of FMO1 in rabbit will be required to verify this
result.50
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ABSTRACT
Our laboratory has previously shown that dietary administration of indole-
3-carbinol (13C) to male Fischer 344 rats has the very unusual property of inducing
hepatic levels of a number of cytochrome P450s (CYPs), especially CYP1A1,
while markedly inhibiting the levels of FMO 1 protein and its catalytic activity. We
hypothesized that rats fed 13C or 3,3 '-diindolylmethane (DIM), one of its major
acid condensation products formedin vivo,should exhibit a marked shift in the
metabolicprofilesof drugsorxenobioticsthataresubstratesfor both
monooxygenase systems. Male rats were fed AIN-76A powdered diets containing
0, 1000 or 2500 ppm 13C or DIM for 4 weeks.Dietary 13C and DIM reduced
FMO1 protein levels (8% reduction with 13C and 84% with DIM at 1000 ppm, and
90% reduction with 13C and 97% with DIM at 2500 ppm) in hepatic microsomes.
Theratioof FMO-(N-oxygenation)toCYP-(N-demethylation)mediated
metabolism of N,N-dimethylaniline (DMA) decreased in liver microsomes from
13C or DIM fed rats from near unity to 0.02 at the highest dietary doses. The ratio
of FMO to CYP metabolites of nicotine decreased, due to a reduction in N-
oxygenation.Similarly, FMO-mediated N-oxygenation (tamoxifen N-oxide) was
decreased, whereas CYP-mediated (N-desmethyl tamoxifen and 4-OH tamoxifen)
metabolism of tamoxifen was unchanged in liver microsomes from rats fed 13C or
DIM.This study demonstrates alteration of FMO and CYP-mediated drug
metabolismin vitroby dietary 13C or DIM and suggests the potential for altered
toxicity of nicotine and tamoxifenin vivo.55
INTRODUCTION
Indoleglucosinolate(glucobrassicin)isthe most abundant ofall
glucosinolates and is found in high concentrations in cruciferous vegetables such as
broccoli, cabbage, cauliflower and Brussels. The glucosinolate hydrolysis products
from myrosinase (thioglucoside glycohydrolase EC 3:2:3:1) at neutral pH are
glucose,sulfate,3 -indolylmethyl isothiocyanate, indole-3-carbinol(13 C) and
thiocyanate ion.13C may condense to 3,3'-diindolylmethane (DIM) and higher
MW oligomers or react with ascorbic acid to form ascorbigen (McDanell et al.,
1988). A number of studies have shown 13C to be chemoprotective against cancer
in multiple target organs such as mammary tissue (Grubbs et al., 1995), liver
(Bailey et al., 1991), endometrium (Kojima et al., 1994), lung (Morse et al., 1990),
and colon (Guo et al., 1995) in animal models.13C has been proposed for
chemoprevention of breast cancer in healthy women (Wong et al., 1997). Both 13C
and DIM are marketed to the public as dietary supplements.
There are many proposed mechanisms involved in the anticarcinogenic
activity of 13C including alteration of phase I and phase II enzymes (Stresseret al.,
1994a; b), free radical scavenging (Arnao et al., 1996) and alteration of the cell
cycle, resulting in the G1 arrest of breast cancer cells (Cover et al.,1998).
However, the anticarcinogenic activity of 13C depends on the timing of 13C
treatment. Chemoprotection is observed when 13C is given before andlor during
carcinogenic exposure (Wattenberg, 1977). Long-term post-initiation exposure can
result in tumor promotion (Bailey etal., 1987).56
Under the low pH conditions of the stomach, 13C undergoesa series of
condensation reactions resulting in the production of various dimers, linear and
cyclic trimers, and tetramers (Bjeldaneset al.,1991). A major product in vivo after
oral administration of 13C (Stresseret al.,1995a) andin vitro(Spande, 1979) is
DIM. When DIM is coinjected with aflatoxin Bi (AFB1), it reduces hepatic
AFB 1-DNA binding and tumor incidence in rainbow trout embryos (Dashwoodet
al.,1994). DIM is a potent non-specific inhibitor of rat and human CYP1A1,
human CYP1A2, and rat CYP2B1 (Stresseret al.,1995b).Chenet al.(1998)
showed that DIM was an aryl hydrocarbon (Ah) receptor ligand and induced
CYP1AI in MCF-7 cells at a concentration of 100 p.M. DIM also inhibited E2-
induced proliferation of MCF-7 cells and down-regulated the nuclearestrogen
receptor. Growth of 7, 12-dimethylbenz[a]anthracene (DMBA)-inducedmammary
tumors in Sprague-Dawley rats was inhibited by DIM at a dose of 5 mg/kg given
every other day under conditions in which no induction of hepatic CYP1A1 was
observed (Chenet al.,1998).
Our laboratory has previously shown that 13C administered in the diet to
male Fischer 344 rats has the very unusual property of inducing hepatic levels ofa
number of cytochromes P450 (CYPs), especially CYP1A, while markedly
inhibiting FMO1 in both a dose- and time-dependentmanner (Larsen-Su and
Williams, 1996). In our current study, we report that 13C and DIM each induced
CYP1A1/1A2 and inhibited the expression and activity of FMO1 in liver of male
rats.Simultaneously, they exhibited a marked shift in the metabolic profiles of57
xenobiotics such as N,N-dimethylaniline and drugs such as nicotine and tamoxifen,
which are substrates for both monooxygenases. Alteration of the FMO/CYP ratio
may have marked effects on toxicological andlor therapeutic properties, depending
upon the drug or xenobiotic.
MATERIALS AND METHODS
Chemicals and Diet
13C was purchased from Aldrich Chemical Co. (Milwaukee, WI). DIM
was the kind gift of Dr. Michael Zeligs of BioResponse L.L.C. (Boulder, CO).
13C and DIM were incorporated into powdered semi-synthetic AIN-76A diet
prepared without preservatives. The diet was prepared just before initiation of the
experiment and stored frozen until the day before feeding. N,N-Dimethylaniline
(15.5 mCi/mmol, UL-ring) was purchased from Sigma Chemical Co. (St.Louis,
MO). (8)-5-3H-Nicotine (32 Ci/mmol), prepared by the catalytic tritiation of (5)-
5-bromonicotine (Shigenaga et al., 1987) was a gift of Dr. Mark Shigenaga. [3H-
N-methyl] Tamoxifen (85.6 Ci/mmol) was obtained from DuPont -NEN (Boston,
MA).
Animals
Four-week-old male Fischer 344 rats were acclimated to A1N-76A diet for 7
days before being switched to AIN-76A diet containing 13C or DIM at levels of 0,1000 or 2500 ppm and fed ad libitum for 4 weeks. The rats were killed by CO2
asphyxiation, and livers were removed, frozen in liquidN2and stored at -80°C until
analysis.The protocols used were approved by the Oregon State University
JACUC.
Microsome Preparation and Immunodetectionof FMOJ
Liver microsomes were prepared by ultracentrifugation according to
Guengerich (1989). Protein was measured by the method of Lowryet al.(1951).
The liver microsomal proteins were separated by sodium dodecyl sulfate-
polyacrylamidegelelectrophoresis(SDS-PAGE)andelectrophoretically
transferred to nitrocellulose membranes (Towbinet al.,1979). The blots were
probed with a polyclonal antibody specific to pig liver FMO1 (a generous gift of
Dr. Daniel Ziegler, University of Texas at Austin), followed with a goat anti-rabbit
secondary antibody conjugated to horseradish peroxidase (Bio-Rad, Richmond,
CA) and then visualized using a chemiluminescense kit (Amersham Corp.,
Arlington Heights, IL). Quantitation was performed by densitometry, using an HP
ScanJet hex flatbed scanner and NIH Image software version 1.54 (public domain,
Wayne Rasband, National Institutes of Health).
N,N Dimethylaniline (DMA) N-oxygenation
FMO and CYP activity toward ['4C]-DMA was determined utilizing a high
performance liquid chromatography assay with a reverse-phase ACT-i column and59
radiochemical detection (Williams, 1991; Shehin-Jolmson et al., 1995).FMO-
mediated N-oxygenation and CYP-mediated N-demethylation can be determined
simultaneously by this method.
Nicotine Metabolism
Nicotine metabolism was assayed according to Williams et al. (1990a).
Nicotine, nicotine N- 1'-oxide, nornicotine and nicotine"5iminjum metabolites
are readily resolved utilizing a Beckman Ultrasphere C18 ODS (5 tm, 4.6 mm x 25
cm) colunm with quantification via on-line radiochemical detection.
Tamoxifen Metabolism
The incubations, containing rat liver microsomes, radiolabeled tamoxifen
and an NADPH-regenerating system in phosphate buffer (pH 7.4), were carried out
as previously described (Dehal and Kupfer, 1997). After a 1 hour incubation, the
reaction was temminated, and metabolites resolved on silica gel TLC plates
(Whatman, Inc., Clifton, NJ) with CHC13: CH3OH: NH4OH (80:20: 0.5% v/v/v).
Radiolabeled metabolites on TLC were analyzed and quantified by radioscanning
using the System 2000 imaging scanner (Bioscan, Inc., Washington, DC).Statistical Analysis
Statistical analyses of the data were performed using Student's t-test.All
data points are the mean ± SD for six rats per group. p values less than 0.05 were
considered significant.
L1jji-
Dietary administration for four weeks of 13C or DIM to male Fischer 344
rats resulted in a dose-dependent reduction in liver microsomal FMO 1 protein
levels (Fig. 3.1) as previously reported by our laboratory for 13C (Larsen-Su and
Williams, 1996). The higher dose of 13C, 2500 ppm, reduced FMO1 protein levels
to 10% that of controls. DIM was markedly more potent than 13C, reducing FMO1
levels to 16% and 3% of controls at 1000 and 2500 ppm, respectively.
N,N-Dimethylaniline metabolism documents clearly the effects of 13C and
DIM on FMO- and CYP-monooxygenation in liver microsomes of rats following
dietary administration (Fig. 3.2).FMO-dependent formation of the N-oxide is
inhibitedinadose-dependentmanner;concurrentlyCYP-dependent N-
demethylation is induced. Consistent with the western blotting results, DIM proved
to be more potent than 13C; the higher dose of 13C reduced N-oxygenation of N,N-
dimethylaniline to 28% of control levels, whereas the inhibition with DIM was to
7% of control levels. CYP-dependent N-demethylation was induced 3-5-fold, but
the effect was not dose-dependent. The ratio of FMO/CYP metabolism of N,N-
dimethylaniline decreased by 50-fold at the higher dose of DIM.61
Although the major CYP-mediated pathways of (S)-nicotine metabolism, N-
demethylation to nornicotine and formation of the A1'5-iminium ion,were
unchanged by dietary 13C or DIM, FMO-catalyzed N-oxygenation of nicotinewas
markedly reduced (Fig. 3.3).
As was the case with nicotine, dietary exposure of rats to 13C and DIM
markedly reduced the N-oxygenation of tamoxifen by liver microsomes withouta
marked increase in CYP-dependent N-demethylation and 4-hydroxylation (Fig.
3.4).a)
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Figure 3.1.Western blotting analysis of FMO 1 protein levels in liver microsomes from rats
treated with 13C or DIM at doses of 1000 and 2500 ppm for 4 weeks. * Indicates significantly
lower than controls at p< 0.05.D)
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Figure 3.2. FMO-dependent N-oxygenation (solid bars) and CYP-dependent N-demethylation
(striped bars) of N, N-dimethylaniline (DMA) in liver microsomes from rats treated with 13C or
DIM at doses of 1000 and 2500 ppm for 4 weeks. N-oxygenation was significantly (p<O.O5)
decreased and N-demethylation significantly increased at all dietary levels of 13C and DIM.E
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Figure 3.3. CYP-and FMO-mediated metabolism of3H-(S)-nicotine. Liver microsomes from
rats fed 0, 1000 or 2500 ppm 13C or DIM for 4 weeks wereincubated with 3H-(S)-nicotine and
the major metabolites nornicotine, nicotineA"5-iminium ion (CYP, hatched bars) and nicotine N-
1 'oxide (FMO, solid bars) resolved and quantified by HPLC asdescribed in materials and
methods. * Indicates significantly lower than controls at p<0.Ol.C)
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Figure 3.4. FMO-mediated TAM N-oxide (solid bars)and CYP-mediated 4-hydroxy TAM and
N-desmethyl TAM (striped bars) formation by livermicrosomes from rats treated with 13C or
DIM at doses of 1000 and 2500 ppm for 4 weeks.* Indicates significantly lower than controls at
p<o.o1.
UIDISCUSSION
Our laboratory and others have documented that dietary exposure of
13C to rats induces a number of CYP isoforms. CYP1A1 is induced by greater than
20-fold, whereas more modest increases of 2-4-fold are observed for CYP1A2,
CYP2B1/2 and CYP3A (Stresseret al.,1994a; Bradfield and Bjeldanes, 1987;
Bjeldaneset al.,1991; Wortelboeret al.1992a; b; Mansonetal.,1998).
Concurrent with this up-regulation of CYP-dependent metabolic pathways in the
rat, the levels of FMO 1 protein and FMO-dependent catalytic activity is markedly
inhibited by dietary 13C in a dose and time-dependent fashion (Larsen-Su and
Williams, 1996).
Based upon these findings, we postulated that dietary 13C exposure could
significantly alter the metabolic profile of drugs and xenobiotics that are substrates
for both monooxygenase systems.The three compounds chosen in the present
study to test this hypothesis, N,N-dimethylaniline, nicotine and tamoxifen, are all
tertiary amines.Tertiary aliphatic amines are typically excellent substrates for
FMO, yielding the water-soluble and usually non-toxic N-oxide metabolites
(Ziegler, 1993).Tertiary aliphatic amines are preferentially N-demethylated by
CYP; in only rare cases in which ct-hydrogens are absent does CYP produce N-
oxides in significant amounts (Guengerich and MacDonald, 1984; Williams et al.,
1989).
In the case of N,N-dimethylaniline, although Hlavica and Kunzel-Mulas
(1993) found that CYP2B4-dependent superoxide anion radical production lead to67
N,N-dimethylaniline-N-oxide production, others studies have found that, relative to
FMO, this pathway is insignificant (Pandeyet a!,1989; Seto and Guengerich,
1993). In the present study, N,N-dimethylaniline-N-oxygenation was inhibited by
dietary 13C in a dose-dependent manner. N-demethylation, presumably mediated
predominantly by CYP2B1, was enhanced 3-5-fold, consistent with our previous
documentation of CYP2B1/2 induction by dietary 13C in these rats (Stresseret al.,
1 994a). The pattern of inhibition of N,N-dimethylaniline N-oxygenation (Fig. 3.2)
closely resembled that of FMO 1 protein repression (Fig. 3.1). At the higher dose of
DIM, greater than 90% of N,N-dimethylaniline-N-oxygenation was inhibited. The
relativecontribution of CYP- and FMO- mediated metabolism of N,N-
dimethylaniline is thus dramatically altered and serves as an example of how 13C
and DIM could alter the therapeutic efficacy andlor toxicity of drugs or xenobiotics
which are substrates for both monooxygenases.
Pretreatment with either 13C or DIM in the diet also altered thein vitroliver
microsomal metabolic profile of (S)-nicotine. CYP-dependent N-demethylation to
nornicotine and formation of the nicotine-A1"5'-iminium ion were unaffected,
whereas, yield of the FMO-catalyzed nicotine N-i '-oxide was reduced to at or
below the limits of detection.
Previous studies have demonstrated that the CYP2A and 2B subfamilies are
active toward nicotine. In rabbit nasal tissue, CYP2A1 0/11 (P45 0 NMa) exhibited
high activity toward nicotine (Williamset al.,1990b).In rat liver, phenobarbital
treatment markedly enhances nicotine C-oxidation, due to induction of CYP2B 1(Hammondet al.,1991). The rabbit ortholog in lung, CYP2B4, is also the major
nicotine oxidase in that organ (Williamset al.,1990a). In human liver, CYP2A6 is
the major isoform catalyzing C-oxidation of nicotine (Berkmanet al.,1995;
Nakajimaet al.,1996; Messinaet al.,1997). Based on the modest induction of
CYP 2B1/2 by 13C in the rat liver, it is somewhat surprising that we saw no
induction of C-oxidation.
Nicotine is oxygenated at the N-i '-position by FMO1 and FMO3 (Damani
et al.,1988; Cashmanet al.,1992; Parket al.,1993).The stereoselective
production of (S)-nicotine trans N-i '-oxide has been proposed as a mechanism for
phenotyping individuals for liver FMO3 (Parket al.,1993). The virtual elimination
of this pathway in liver microsomes from rats fed high concentrations of 13C and
DIM, isconsistent with the down-regulation of FMO1 protein and N,N-
dimethylaniline N-oxygenation discussed above. It could be speculated that 13C or
DIM inhibition of nicotine- N-i '-oxide production in vivo could alter the
pharrnacokinetics of nicotine and provide protection against nicotine addiction and
reduce the number of cigarettes smoked in a manner analogous to that seen with the
polymorphism which results in non-functional CYP2A6 (Pianezzaet al.,1998). It
has been observed that trimethylaminuria (a genetic defect in FMO3) patients
exhibit impaired nicotine N-1'-oxygenation (Ayeshet al.,1988). One major caveat
to this hypothesis involves the question of whether or not human liver FMO3
responds to dietary 13C and DIM as does rat liver FMO1.Tamoxifen, an antiestrogen, is the therapeutic drug most often used in the
treatment of breast cancer (Jordan, 1993) and, based on the results of a recent large
clinical trial, is advocated as a chemopreventive agent for women at high risk of
developing breast cancer (Fisheret al.,1998). Of concern with the long-term use
of tamoxifen is an enhanced incidence of endometrial cancers (Killackeyet al.,
1985) and the observation that it is hepatocarcinogenic in the rat (Williamset al.,
1993). Tamoxifen is bioactivated by CYPs to yield 4-hydroxytamoxifen which is
markedly more potent as an antiestrogen than the parent compound (Jordanet al.,
1977).Another major CYP metabolite is N-desmethyl tamoxifen.Further
hydroxylation of 4-hydroxytamoxifen results in formation of tamoxifen catechol, a
redox active metabolite that covalently binds to macromolecules (Dehal and
Kupfer, 1999). The major CYPs active toward tamoxifen and 4-hydroxytamoxifen
are CYP3A4, 2D6 and 2C9 (Dehal and Kupfer 1997; 1999; Creweet al.,1997). N-
oxygenation of tamoxifen is mediated by FMO and the N-oxide is found in the
serum of women taking the drug (Maniet al.,1993; Poon et al., 1995).
In this study we document a significant reduction in the N-oxygenation of
tamoxifen catalyzed by liver microsomes of rats fed 13C or DIM.In liver
microsomes from control rats, the ratio of CYP-mediated N-demethylation and 4-
hydroxylation to FMO-mediated N-oxygenated is approximately unity; at the
higher dose of 13C and both doses of DIM, the ratio increases to 3-4. A reduction
in N-oxygenation may actually decrease tamoxifen toxicity.Previous work has
provided evidence that FMO activity could enhance tamoxifen-dependent covalent70
binding (Math and Kupfer, 1991).Recent studies document that tamoxifen N-
oxide and metabolites covalently bind to DNA and the authors state that there is
evidence for dG-N2-tamoxifen N-oxide DNA adducts in human (Umemotoet al.,
1999). Based on these findings, we hypothesize that, if a similar alteration occurs
in humans, women taking tamoxifen, in concert with diets high in cruciferous
vegetables andlor taking 13C supplements, could enhance their risk of developing
toxic side effects.
As mentioned above, whether or not these present studies with rat can be
extrapolated to humans could depend, in large part, on whether or not down-
regulation of human liver FMO3 is analogous to rat FMO1.Humans fed 300
g/day of Brussels sprouts, providing an estimated dose of 0.002-0.014 mmol
13 C/Kg/day, exhibited a significant decrease in urinary trimethylamine N-oxide,
presumably due to inhibition of liver FMO3 (Cashmanet al.,1999). This dose is
markedly lower than the highest inhibitory dose of dietary 13C (0.46 mmol
/Kg/day) given to rats in this study. It must be kept in mind, however, that Brussels
sprouts contain numerous other phytochemicals including isothiocyanates and
dithiolanes that may effect FMO.
It may not be necessary for FMO3 protein to be down-regulated by 13C (as
is the case with rat liver and intestinal FMO 1) to observe inhibition, as we have
found that 13C acid condensation products can directly inhibit FMO catalytic
activity. DIM and indole[3,2-b]carbazole (ICZ) inhibited the catalytic activity of
rat FMO1in vitrowith K1s of 47 and 31 tiM, respectively (Larsen-Su, 1998). ICZ,71
DIM and 13C also directly inhibit the catalytic activity of the major FMO in human
liver, FMO3, with K1s in the low tM range (Cashmanet al.,1999). Of these three
compounds, only DIM would be expected to be present in liver following 13C oral
administration at levels capable of eliciting this response.Studies following the
pharmacokinetics of 3H-13C after oral administration to rats found no 13C in liver
and ICZ levels were estimated to be 1.6 nM, however DIM levels were estimated to
be 3-6 M (Stresseret al.,1995a). Interestedly, DIM also directly inhibits rat and
human CYP1A1, human CYP1A2 and rat CYP2B1 with K1s again in the low p.M
range (Stresseret al.,1995b). In this study DIM was demonstrably more effective
than 13C. The 1000 and 2500 ppm diets correspond to 6.2 and 15.5 mmoles[Kg for
13C and 4.1 and 10.2 mmoles/Kg for DIM; therefore DIM was even more effective
on a mole basis.
In summary, we have demonstrated that administration of the indoles 13C
and DIM, present in cruciferous vegetables and sold as dietary supplements,
markedly alter the metabolism in vitro of drugs that are substrates for both CYP
and FMO monooxygenases. Dietary 13C and DIM inhibit the expression of FMO1
protein. Furthermore, DIM is capable of directly inhibiting the catalytic activity of
FMO1 and FMO3 as well as a number of CYPs. The consequences of this "drug-
drug" interaction could be manifest as alterations in therapeutic efficacy or toxicity.72
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Chapter 4
INHIBITION OF FMO-MEDIATED CODEINE ANALGESIA BY DIETARY
INDOLE-3-CARBINOL AND 3,3'-DIINDOLYLMETHANE IN THE RAT
S. Katchamart, and D.E. Williams
Department of Environmental and Molecular Toxicology
Oregon State University, Corvallis, OR79
ARSTP ACT
Dietary administration of indole-3-carbinol (13C) to male Fischer 344 rats
has been shown to markedly induce many Phase I and Phase II enzymes , while
inhibiting the expression and activity of FMO1. To test the effect of 13C or 3,3'-
diindolylmethane (DIM), the major breakdown product of 13C, on the metabolism
of xenobiotics which are the substrates for both monooxygenases in vivo, rats fed
13C or DIM were gavaged with codeine and analgesic efficacy estimated by the tail
flick assay. The time from onset of the heat stimulus to withdrawal of the tail was
longer in rats treated with 13C or DIM than in controls. However, the results were
highly variable between rats.Western blotting showed that both 13C and DiM
significantly reduced FMO1 protein. CYP2D1 activity was significantly increased
in liver microsomes pretreated with 13C or DIM.Further study is needed to
confirm the difference in the tail flick assay between control and treated groups by
increasing the sample size and finding a response that doesn't have to be censored.INTRODUCTION
Indole-3-carbinol is the hydrolysis product of indole glucosinolate, which is
found in high concentration in cruciferous vegetables such as broccoli, cabbage,
cauliflower and Brussels sprouts (McDanell et al., 1988). Numerous studies have
shown 13C to be chemoprotective against cancer in multiple target organs such as
mammary tissue (Grubbs et al., 1995), liver (Bailey et al., 1991), endometrium
(Kojima et al., 1994), lung (Morse et al., 1990) and colon (Guo et al., 1995) in
animal models. Alteration of phase I and phase II enzymes (Stresser et al., 1994a;
b), free radical scavenging (Arnao et al.,1996), modulation of intercellular
communication (Rijinkels et al., 1998), and alteration of cell cycle (Cover et al.,
1998) are proposed mechanisms involved in the anticarcinogenic activity of 13C.
13C is not a stable compound, especially under the low pH conditions of the
stomach.13C undergoes a series of condensation reactions resulting in the
production of various dimers, linear and cyclic trimers, and tetramers (Bj eldanes et
al., 1991). A major product in vivo after oral administration of 13C (Stresser etal.,
1995) and in vitro (Spande, 1979) is 3,3'-diindolylmethane (DIM). Like 13C, DIM
decreases aflatoxin B 1-induced liver tumors in rainbow trout (Dashwood et al.,
1994) and 7,12-dimethylbenz{a]anthracene (DMBA)-induced mammary tumor
growth in rat (Chen et al., 1998).
Dietary administration of 13 C to male rats markedly induced levels of
hepatic CYP1A1, while dramatically down-regulated both the expression and
activity of flavin-containing monooxygenase (FMO), form 1(Larsen-Su and81
Williams, 1996). Our previous study documented the alteration of FMO and CYP-
mediated N, N-dimethylaniline, nicotine and tamoxifen in vitro by dietary 13C or
DIM.The objective of this study was to determine the analgesic response of
codeine mediated by FMO and CYP in rats treated with 13C or DIM.
MATERIALS AND METHODS
Chemicals and Diet
13C was purchased from Aldrich Chemical Co. (Milwaukee, WI). DIM
was the kind gift of Dr. Michael Zeligs, BioResponse L.L.C. (Boulder, CO). 13C
and DIM were incorporated into powdered semi-synthetic AIN-76A diet prepared
without preservatives.The diet was prepared just before initiation of the
experiment and stored frozen until the day before feeding. Rabbit anti-hog liver
FMO1 was a generous gift of Dr. Daniel Ziegler, University of Texas at Austin.
Goat anti-rabbit secondary antibody conjugated to horseradish peroxidase was
from Bio-Rad (Richmond, CA). The chemiluminescence kit was obtained from
Amersham Corp. (Arlington Heights, IL). Bufuralol and 1 '-hydroxylbufuralol
were from Gentest (Wobum, MA).
Animals
Four-week-old male Fischer 344 rats were acclimated to AJIN-76A diet for 7
days before being switched to AIN-76A diet containing 13C or DIM at doses of 0and 2500 ppm and fed ad libitum for 10 weeks.The rats were gavaged with
codeine 25 mg in 0.9% NaC1, and the analgesic effect detennined by the tail flick
assay (measurements of codeine analgesia were made at 0, 15, 45 and 90 mins).
The rats were killed by cervical dislocation, livers were removed, frozen in liquid
N2and stored at -80°C until analysis.
Tail Flick Assay
The analgesic response was measured by exposure of the rat's tail to radiant
heat. With the rat held in a restraining tube, heat was focused on a surface area of
the rat's tail. For each rat, the time from onset of the stimulus to withdrawal of the
tail was recorded and determined as time0. After gavage of codeine 25 mg, the
time from onset of the stimulus to withdrawal of the tail was measured at 15, 45
and 90 mm. The maximum time for the tail to be exposed to the heat was set at 15
sec to avoid tissue injury caused by long exposure to the heat stimulus (Beacher,
1957).
Microsome Preparation and ImmunodetectionofFMO1
Liver microsomeswere prepared by ultracentrifugationaccording to
Guengerich (1989). Protein was measured by the method of Lowryet al.(1951).
The liver microsomal proteins were separated by sodium dodecyl sulfate-
polyacrylamidegelelectrophoresis(SDS-PAGE)andelectrophoretically
transferred to nitrocellulose membranes (Towbinet al.,1979).The blots wereincubated in 2% BSA in phosphate buffer saline (PBS), followed with a rabbit anti-
hog liver FMO1. After washing in PBS-Tween 20, the blots were probed with a
secondary antibody conjugated to horseradish peroxidase and then visualized using
a chemiluminescense kit.Quantitation was performed by densitometry, using an
HP ScanJet IIcx flatbed scanner employing NIH Image version 1.54 software
(public domain, Wayne Rasband, National Institutes of Health).
Bufuralol 1 '-Hydroxylase assay
CYP2D 1activity was determined in liver microsomes, as previously
described (Kronbach et al., 1987).The final reaction mixture contained 1 mM
bufuralol in 0.1 M potassium phosphate pH 7.4, 20 mg/mi glucose 6-phosphate, 20
mg/mi NADP,13.3mg/mi MgC12-H20,40 U/miglucose6-phosphate
dehydrogenase in 5 mM sodium citrate, 0.1 M potassium phosphate pH 7.4 and 50
p.g microsomal protein in a volume of 250 .tl. Samples were preincubated at370 C
for 5 minutes before initiating the reaction with bufuralol.The reaction was
terminated at 20 minutes with the addition of cold 60% perchloric acid 25 j.ti,
cooled on ice 10 mm and centrifuged at 10,000 g for 20 mmat 40 C to precipitate
protein.The 1 '-hydroxybufuralol was quantified by HPLC with fluorescence
detection: excitation at 252 nm and emission at 302 nm. The mobile phase was
37% acetonitrile, 63% water and 0.9 mM perchioric acid. The colunm used was a
Beckman Ultrasphere C-18 analytical column, 4.6 mm x 25 cm, 5 .tm pore size.
The flow rate was constant at 1 mllmin.Statistical Analysis
The tail flick assay data were analyzed by Kruskal-Wallis test.Statistical
analyses of immunoquantitation of the FMO1 protein and CYP2D1 activity were
performed using Student's t-test. All data points are the mean ± SD. p values less
than 0.05 were considered significant.
RESULTS
After feeding 2500 ppm of 13C or DIM for 10 weeks, the rats were gavaged
with 25 mg codeine and the analgesic effect followed by the tail flick assay. The
time from onset of the heat stimulus to withdrawal of the tail was longer in rats fed
13C or DIM than in controls. However, the result showed great variability in the
response between rats. There was no response within 15 seconds in 3/4 rats fed 13C
(Fig 4.1). There was no response within 15 seconds in 1/4 rats fed DIM (Fig 4.2).
Other 13C- and DIM- treated rats responded similarly to controls. Western blotting
showed that both 13C and DIM significantly reduced FMO1 protein levels (23%
13C and 31% DIM) (Fig. 4.3) as previously reported by our laboratory for 13C
(Larsen-Su and Williams, 1996). In liver microsomes pretreated with 13C or DIM,
the CYP2D1 activity, as determined by using bufuralol as the substrate, increased
52% and 85% in the 13C and DIM groups, respectively (Fig. 4.4).20
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Figure 4.2 The analgesic response for codeine administration to 13C-pretreated rats.
Tail flick responses were measured at time 15, 45 and 90 mm after codeine administration.20 o Control 1
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Figure 4.2 The analgesic response for codeine administration to DIM-pretreated rats.
Tail flick responses were measured at time 15, 45 and 90 mm after codeine administration.20
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Figure 4.3.Western blotting analysis of FMO1 protein levels in liver
microsomes from rats fed 13C or DIM at doses of 2500 ppm for 10 weeks.*
Indicates significantly lower than controls at p< 0.05.c,)
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Figure 4.4.The CYP2D1 activity as the bufuralol 1 '-hydroxylation in liver
microsomes from rats fed 13C or DIM at doses of 2500 ppm for 10 weeks. *
Indicates significantly higher than controls at p< 0.05.DISCUSSION
Dietary administration of indole-3-carbinol (13C) to male Fischer 344 rats
has been shown to markedly induce many Phase I (Bjeldanes et al.,1991;
Wortelboer et al., 1992; Jellinck et al., 1993; Stresser et al., 1994a) and Phase II
(Spamius et al., 1982; Salbe and Bjeldanes, 1986; Danger et al., 1992; Wortelboer
et al., 1992) enzymes, while inhibiting the expression and activity of FMO 1
(Larsen-Su and Williams, 1996).Our previous study demonstrated that liver
microsomes from rats fed 13C or DIM decreased the in vitro ratio of FMO to CYP
metabolites of N, N-dimethylaniline, nicotine and tamoxifen, due primarily to
reduction in FMO-N-oxygenation.In order to investigate the in vivo effect of
alteration of the FMO/CYP ratio on the drugs or xenobiotics that are substrates for
both monoxygenase systems, rats fed 13C or DIM were gavaged with 25 mg
codeine followed determination of analgesic efficacy by the tail flick assay. The
test compound in the present study was codeine, a tertiary amine substrate for
FMO, (Ziegler,1993).Codeine (methylmorphine) is an ancient analgesic,
antitussive and anti-diarrhea! drug whose therapeutic effects are principally
produced by the 0-desmethylated metabolite, morphine, catalyzed by CYP2D6 in
human (Yue et al., 1989) and CYP2D1 in the rat (Xu et al., 1995). CYP3A4
appears responsible for norcodeine formation, the N-demethylation product
(Caraco et al., 1996). FMO catalyzes the N-oxygenation of both codeine and
morphine, resulting in pharmacologically inactive metabolites (Yuno et al., 1990).The genetic polymorphism known as the debrisoquine polymorphism
results in people being phenotyped as either poor or extensive metabolizers (PM
and EM), based on CYP2D6 activity. Although CYP2D6 makes up only about 2-
5% of the total CYP45O in the human liver, it is the major enzyme catalyzing
metabolism of more than 30 clinically used drugs, including all of the tricyclic
antidepressants, several neuroleptics, opiates, betablockers, and antiarrhythrnics
and,amongtheselectiveserotoninreuptakeinhibitors(SSRIs),N-
desmethylcitalopram, fluvoxamine and fluoxetine (Brsen, 1998).Eckhardt et al.
(1998) showed that the percentage of the codeine dose (170 mg, p.o.) converted to
morphine and its metabolites was 3.9% in EMs and 0.17% in PMs, resulting in the
difference in analgesic response of codeine.
After dietary administration for ten weeks of 13C or DIM to male Fischer
344 rats, the animals were gavaged with 25 mg of codeine. The analgesic response
was measured, using the tail flick assay. The tail flick response is a spinal reflex
that rarely occurs spontaneously. This assay has been used for pharmacodynamics
studieswith many opioidanalgesicssuchasmorphine, oxycodone and
oxymorphone (Plummeret al.,1990).
Although there was no statistical difference between controls and treatment
groups in the tail flick assay due to highly variable response between rats, FMO1
protein expression and CYP2D1 activity in liver microsomes showed a significant
difference between control and treatment groups.The western blotting result
showed that 13C and DIM reduced hepatic FMO1 protein levels. The CYP2D191
activity in liver microsomes pretreated with 13C or DIM was significantly induced,
compared to control. Our results suggested that the enhanced analgesic effect (if
real) was possibly due to higher morphine in 13C- or DIM- treated rats, resulting
from a decrease of N-oxide metabolites of codeine and morphine by FMO1 andlor
induction of morphine production by CYP2D 1.
The analgesic action of codeine in rat was mediated by morphine formation
both in the brain and in the liver (Chenet al.,1990). Bergh and Strobel (1996) also
showed the presence of P4502D mRNA in rat brain. Baum and Strobel (1996)
showed that in ovariectomized rats, testosterone dramatically increases CYP2D
expression, while estrogen increases a modest CYP2D expression in rat brain.
Previous studies revealed the endocrine effects of 13C, for example, 13C induced
plasma. vitellogenin, the biomarker for estrogenic activity in rainbow trout
(Oganesianet al.,1999).In uteroexposure to a single dose of 13C (1.0 or 100
mg/kg) causes abnormalities in the male rat offspring including decreased sperm
production and decreased transit rate of sperm (Wilkeret al.,1996). The presence
of FMO in brain of human (Bhamreet al.,1995) and rat (Bhamreet al.,1993) has
been documented. The question to now address is whether or not 13C including its
acid condensation products can alter the expression of FMO and CYP2D in the
brain which would require passage through blood brain barrier and then whether
they can exhibit estrogenic activity in the brain.
If our study with rat can be extrapolated to human, EM of both sexes taking
codeine along with a diet rich in cruciferous vegetables and/or taking 13C92
supplements could enhance the analgesic response to codeine and perhaps
experience other side effects due to FMO 1 protein repression, CYP2D 1 activity
induction and possible sex hormone effects.We cannot provide statistically
significant data from this study because of the small sample size and the instrument
set up that required termination of the stimulus at 15 seconds.Future studies
should be done not only to find the effect of 13C or DIM on the analgesic response
of codeine, but also to examine CYP2D1 activity and FMO expression in brain.
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Chapter 5
IN VIVO ESTROGENIC ACTIVITY OF INDOLE-3-CARBINOL AND 3,3'-
DIINDOLYLMETHANE IN RAINBOW TROUT AND IMMATURE
FEMALE RAT
S. Katchamart, D.B. Carison, A. Shilling and D.E. Williams
Department of Environmental and Molecular Toxicology
Oregon State University, Corvallis, ORABSTRACT
Indole-3-carbinol (13C), the most abundant metabolite of glucobrassicin, is
found in cruciferous vegetables.The primary breakdown product of 13C in
aqueous solution, acidic solution, and in vivo after oral administration is 3,3'-
diindolylmethane (DIM). 13C and DilvI bind to the Ah receptor witha binding
affinity of 2.6xi0and7.8xi0, respectively,relativeto2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD).Both compounds also inhibit DMBA-
induced mammary tumor growth in the rodent model. Thepurpose of this study
was to investigate the estrogenic effect of both compounds in rainbow trout and
immature female Sprague-Dawley rat.In trout fed 1000 ppm 13C, plasma
vitellogenin, a biomarker of estrogenicexposure, was induced on days 5, 10, 15
and 20. Plasma vitellogenin was also induced in trout treated with100-2000 ppm
13C or 10-250 ppm DIM for 2 weeks, in a dose-dependentmanner. Rats were fed
with a diet containing 13C or DIM for 5 days. 13C (25-2000 ppm) andDIM (10-
250 ppm) significantly induced uterine peroxidase activity.13C (25-2000 ppm)
induced hepatic CYP1A1/1A2, CYP2B1/2B2 and CYP3A2 protein levelsin a
dose-dependent fashion.Hepatic CYP1A1/1A2, CYP2B1/2B2 and CYP3A2
proteins were induced by given DIM at doses of 250ppm, 10-250 ppm, and 10-250
ppm, respectively. DIM-induced estrogenic response can be observed at doses of
10-100 ppm, at which dose CYP1A1/1A2 induction is undetectable,suggesting that
the estrogenic activity at these doses may be Ah-R independent.INTRODUCTION
Indole-3-carbinol (13C), a naturally occurring component of cruciferous
vegetables such as broccoli, cabbage, cauliflower and Brussels sprouts, has been
shown to increase the activity of phase I and II enzymes including CYP 1 Al,
CYP1A2, CYP2B1/2B2, CYP3A2 and glutathione S-transferase (Stresseret al.,
1994a,b).Alteration of biotransformationenzymes affectsthetoxicity,
mutagenicityandtumorigenicityof specificcompounds.Forexample,
administration of 13C prior to aflatoxin Bi (AFB1) exposure in rainbow trout
(Dashwoodet al.,1988) and rat (Stresseret al.,1994b) decreases AFB1-DNA
binding in liver and lowers the incidence of liver tumors. In mice, 13C given prior
to CCL3 (Shertzeret al.,1988) or N-nitrosodimethylamine (NDMA) (Shertzer,
1984)protected against hepatotoxicity and decreased NDMA-DNA binding,
respectively.However, the liver tumor rate was higher in rainbow trout treated
with 13C after AFB1 exposure (Nixonet al.,1984). The timing of 13C exposure
is important in determining the activity of 13C as tumor inhibitor or promoter
(Wattenberg, 1977; Dashwood et al., 1991).
A significant reduction in the incidence of spontaneous mammary tumors in
C3H/OuJ mice (Bradlowet al.,1991) and spontaneous endometrial cancer in
Donryu rats (Kojimaet al.,1994) was observed when 13C was incorporated in the
diets. 13C also increased the estrogen metabolite ratio of 2-hydroxyestrone to 16-a
-hydroxyestrone in MCF-7 cells (Tiwariet al.,1994) and in urine of women taking
a 300 mg oral dose of 13C for 4 weeks (Wonget al.,1997).It was suggested that100
13 C increased estradiol 2-hydroxylation, mainly catalyzed by CYP 1 A2, resulting in
reduced estrogenic activity. Interestingly, estradiol-responsive MCF-7 cells were
more sensitive to the growth inhibitory effects of 13C than the estradiol-
nonresponsive MDA-MB-231 cells (Tiwariet al.,1994).
A primary breakdown product of 13C in aqueous, acidic solution (Spande
1979), and in vivo after oral administration (Stresseret al.,1995) is3,3'-
diindolylmethane (DIM). Hepatic CYP1A1/1A2, CYP2B1/2B2 and estradiol 2-
hydroxylase were induced in rat after treatment with DIM (Jellincket al.,1993).
DIM also induced quinone reductase and UDP-glucuronosyl transferase in rat
hepatocytes (Wortelboeret al.,1992). DIM and 13C bind to the aryl hydrocarbon
(Ah) receptor with a binding affinity of 7.8 x 1 0and 2.6x1 0, respectively,
relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Bjeldaneset al.,1991).
DIM inhibitedestrogen-inducedproliferationof MCF-7celland7,12-
dimethylbenz[a]anthracene (DMBA)-induced mammary tumor growth in Sprague-
Dawley rats (Chenet al.,1998). DIM induced apotosis in human breast cancer
cells and the induction was independent of the p53 pathway (Geet al.,1996).
13C has shown chemopreventive activity in several different animal models,
and is now in the clinical development for prevention of breast cancer, endometrial
cancer and other estrogen-related cancers.Little is known, however, about
endocrine effects of 13C.Therefore, more detailed information is needed to
determine the risk of endocrine effects when taken asa supplement for101
chemoprevention in humans.The purpose of this study was to investigate the
estrogenic effects of 13C and DIM in rainbow trout and immature female rat.
MATERIALS AND METHODS
Chemicals
13C was purchased from Aldrich Chemical Co. (Milwaukee, WI). DIM was
the kind gift of Dr. Michael Zeligs, BioResponse L.L.C. (Boulder, CO). Tamoxifen
was from Sigma Chemical Co. (St. Louis, MO).Rabbit anti-chum salmon
vitellogenin IgG and purified vitellogenin were provided by Dr. D.R. Buhler
(antibody was originally isolated by Dr. A. Hara: Hara et al., 1993). Goat anti-rat
CYP1A1/1A2, CYP2B1/2B2 and CYP3A2 were obtained from Gentest (Wobum,
MA). Rabbit anti-goat secondary antibody conjugated to horseradish peroxidase
was from Bio-Rad (Richmond, CA).Biotinylated donkey anti-rabbit IgG,
streptavidin linked horseradish peroxidase and the chemiluminescence kit were
purchased from Amersham Corp. (Arlington Heights, IL).Other chemicals were
all reagent grade and commercially available.
Animals
Rainbow trout(Oncorhynchus mykiss),Shastastrain,rearedatthe
Marine/Freshwater Biomedical Sciences Center fish hatchery and histopathology
facility at Oregon State University were used in all studies. The test compounds102
were incorporated into Oregon Test Diet (OTD), a semi-purified trout diet, and
expressed as parts per million (ppm) of dietary wet weight.In the time course
study, three groups of 30 fry (weight approximately 10-20 g) were fed 1000 ppm
13C, 10 ppm tamoxifen or 1000 ppm 13C plus 10 ppm tamoxifen. On days 5, 10,
15and 20,fry (sevenfry/group) were anesthetized by an overdose of
tricainemethanesulfonate (MS222) to collect blood. In another study, two-year-old
rainbow trout were fed 13C (50, 100, 250, 500, 1000 and 2000 ppm) and DIM (2.5,
10, 25, 50, 100 and 250 ppm) for two weeks before collected blood.
Twenty-one-day-old female Sprague-Dawley rats were acclimated to an
AIN-76A diet for 7 days before being switched to AIN-76A diet containing 13C
(25, 100, 250, 500, 1000 and 2000 ppm), DIM (2.5, 10, 25, 100 and 250 ppm) or
173-estradiol (1 ppm) and fed ad libitum for 5 days. The rats were killed by CO2
asphyxiation, and livers and uterus were removed, frozen in liquidN2and stored at
80°C until analysis.
Vitellogenin Analysis
Plasma vitellogenin was determined by competitive enzyme linked
immunosorbent assay (ELISA), according to Donohoe and Curtis (1996).High
affinity 96-well plates were coated with 100t1Iwell of purified rainbow trout
vitellogenin standard in 0.05 M sodium carbonate buffer (pH 9.6) 250 ng/ml and
incubated overnight at 4°C.Standard vitellogenin or diluted plasma sample
containing 1% BSA and rabbit anti-chum salmon vitellogenin IgG were added in103
low affinity 96-well plates and stored overnight at 4°C. After washing high affinity
plates with phosphate buffer-saline-0.05% Tween 20 (PBST), non-specific binding
was blocked with 1% BSA in PBST. The standard vitellogenin and samples were
transferred to high affinity plates and stored overnight at 4°C. After washing, the
plates were incubated with anti-rabbit IgG, followed with strepavidine-horseradish
peroxidaseat37°Candthenvisualizedbyaddingthe3,3',5,5'-
tetramethylbenzidine dissolved in DMSO, 0.01% H202 (30%) and 0.01 M sodium
acetate buffer, pH 6.0. The color development was stopped by adding 10% H2SO4
after 20 mm incubation. Absorbance was measured at 450 nm on a Bio-Tek EL340
plate reader.
Microsome Preparation and Western Blot Analysis
Liver microsomes were prepared by ultracentrifugation (Guengerich, 1989).
Protein was quantified by the method of Lowry et al. (1951). Microsomal proteins
were separated on an 8% SDS-PAGE (Laemmli, 1970), and electrophoretically
transferred to nitrocellulose (Towbin et al., 1979). The blots were incubated in 2%
BSA in PBS, followedwith goat anti-rat CYP1A1/1A2,CYP2B1/2B2 or
CYP3A2.The membranes were probed with a rabbit anti-goat secondary
conjugatedtohorseradishperoxidaseandthenvisualizedusinga
chemiluminescence kit. Quantitation was performed by densitometry, usingan HP
ScanJet IicX flatbed scanner and NIH Image software version 1.54(public
domain, Wayne Rasb and, National Institutes of Health).104
Uterine Peroxidase Assay
After each uterus was removed and trimmed free of fat, the uterine horn
bisections from each group were pooled, homogenized in ice cold Tris-buffer (10
mM Tris-HC1, pH 7.2) and centrifuged for 45 mm at 39,000 g at 40 C. The pellets
were rehomogenized in TC buffer (10 mM Tris-HC1, 0.5 mMCaC12,pH 7.2) and
centrifuged at 39,000 g for 45 mm at 4°C. The reaction was started by adding 450
p.! of assay mixture (13mM guaiacol and 0.3mMH202in the TC buffer) and 150
p.! supematant (1 mg/mI protein) to a cuvette and guaiacol oxidation was recorded
for 1 mm on a spectrophotometer at 470 nm. Three determinations were performed
from each pooled extract (Dickenson et al., 1992).
Statistical Analysis
Statistical analyses of the data were performed using Student's t-test.All
data points are the mean ± SD for four animals per group. The p values less than
0.05 were considered significant.
RESULTS
Results of the time course study showed that dietary administration of 1000
ppm 13C to trout produced a time-dependent induction in plasma vitellogenin (Fig.
5.1). Tamoxifen alone also induced vitellogenin production (10.2-307.8 p.g/ml),
compared to control (3.9-2.9 p.g/ml: data not shown) from day 5-20. Cotreatment105
of trout 1000 ppm 13C plus 10 ppm tamoxifen significantly reduced vitellogenin
levels 23%, 25%, 15% and 44% on day 5, 10, 15 and 20, respectively, compared to
1000 ppm 13C alone. Plasma vitellogenin on day 5, 10, 15 and 20 was induced
significantly in fish treated with 13C, tamoxifen and 13C plus tamoxifen.
Two week dietary exposure to 25-2000 ppm 13C or 2.5-250 ppm DIM
resulted in the production of vitellogenin in a dose-dependent manner (Fig. 5.2-
5.3). A statistically significant increase in plasma vitellogenin was observed in
trout treated with 250-2000 ppm 13C and 50-250 ppm DIM.
13C (25-2000 ppm) and DIM (10-250 ppm) significantly induced uterine
peroxidase activity, related to control rat (0.00 1 unit/mg protein) (Fig. 5.4-5.5).
However, there were no dose-dependent effects in uterine peroxidase activity for
both compounds.17-Estradiol (1 ppm), with uterine peroxidase 5.4 units/mg
protein, served as the positive control for this experiment.Densitometry results
following western blotting showed the effects of five days of dietary feeding 13C
(25-2000 ppm) or DIM (2.5-250 ppm) on liver CYP1A1/1A2, CYP2B1/2B2 and
CYP3A2 in immature female rat (Fig. 5.6-5.7). No CYP1A1/1A2 or CYP2B1/2B2
was detected in liver microsomes from control rats.13C (25-2000 ppm)
significantly induced hepatic CYP1A1/1A2, CYP2B1/2B2 and CYP3A2 protein
levels in a dose-dependent fashion. Hepatic CYP1A1/1A2 and CYP2B1/2B2
protein were induced by DIM at doses of 250 ppm, and 10-250 ppm, respectively.10
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Figure 5.1. Time-course of plasma vitellogenin after 5-20 days dietary feeding
1000 ppm 13C (striped bars), 10 ppm tamoxifen (white bars) and 1000 ppm 13C
plus 10 ppm tamoxifen 10 ppm (black bars) in rainbow trout.C
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Figure 5.2. Dose-response of plasma vitellogenin after 2 weeks dietary feeding
0-2000 ppm 13C in rainbow trout. * Indicates significantly different from
controls at p< 0.05.E
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Figure 5.3. Dose-response of plasma vitellogemn after 2 weeks dietary feeding
0-250 ppm DIM in rainbow trout. * Indicates significantly different from
controls at p< 0.05.ci)
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Figure 5.4. Dose-response of uterine peroxidase activity in the immature female
Sprague-Dawley rat after 5 days dietary feeding 0-2000 ppm 13C. * Indicates
significantly different from controls at p< 0.05.a)
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Figure 5.5. Dose-response of uterine peroxidase activity in the immature female
Sprague-Dawley rat after 5 days dietary feeding 0-25 0 ppm DIM. * Indicates
significantly different from controls at p< 0.05.400
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Figure 5.6. Dose-response ofCYP1A1/1A2(striped bars),CYP2B1/2B2(white
bars) and CYP3A2 (black bars) after 5 days dietary feeding 0-2000 ppm 13C in
immature female rat.* Indicates significantly different from controls atp<
0.05.a)
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Figure 5.7. Dose-response ofCYP1A1/1A2 (striped bars), CYP2B1/2B2 (white
bars) and CYP3A2 (black bars) after 5 days dietary feeding 0-250 ppm DIM in
immature female rat. * Indicates significantly different from controls at p< 0.05.113
DISCUSSION
Mature female oviparous animals produce vitellogenin, an egg yolk protein
precursor under the direct control of estrogen, but male and immature animals can
also produce vitellogenin in response to estrogen. Vitellogenin has been usedas a
biomarker of estrogen and xenoestrogen exposure (Sumpter and Jobling, 1995;
Donohoe and Curtis, 1996).Results from the time course study showed that in
rainbow trout 10 ppm tamoxifen was weakly estrogenic compared to the effectseen
with 1000 ppm I3C. The same dose of tamoxifen when given simultaneously with
13C only partially inhibit I3C-mediated vitellogenin production, suggesting that the
trout estrogen receptor mRNA and vitellogenin mRNA transcription were saturated
by 1000 ppm 13C (Flouriotet al.,1996). Carisonet al.(1997) also showed that
tamoxifen inhibited estrogen-mediated vitellogenin production only at sub-maximal
estrogen doses.
DIM induced higher vitellogenin production than 13C at the same dose.
Dashwoodet al.(1989) showed that after given a single dose of 13C at 40 mg/kg
body weight in the diet or by gavage for 48 hours, DIM comprised up to 40% of the
total hepatic 13C condensation products in trout (1-1.5% of the 13C dose). Ifwe
assumed that 13C was metabolized to 1% DIM in trout liveras in Dashwood's
study, then 1000 ppm 13C would be equivalent to 10 ppm DIM.However,
vitellogenin induction by 13C at 1000 ppm was higher than that by DIM 10ppm,
13 fold. One possible explanation was other 13C acid condensation products had
estrogenic activity.114
13C (25-2000 ppm) and DIM (10-250 ppm) significantly induced uterine
peroxidase activity, suggesting that the doses of both compounds were estrogenic
in rat. Interestingly, the estrogenic activity of 13C and DIM was observed at doses
of 25-2000 ppm, whereas CYP1A1/1A2 was induced at a dose of 250 ppm. It was
possible that the estrogenic activity of DIM at doses of 10-100 ppm was Ah
receptor independent.
13C and DIM are estrogenic in a nonmammalian (trout) and mammalian
(rat) models as determined by induction of plasma vitellogenin and uterine
peroxidase, respectively. The results from this study suggested that 13C and DIM
may act either as estrogens or antiestrogens depending on the target. However, the
promotional potential of 13C and DIM in animal models for both hormone-
independent and dependent tumors, and the relation to human cancer risk, should
be investigated before these compounds are used asthe supplements for
chemoprevention.115
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SUMMARY
Our laboratory has previously shown that dietary administration of indole-
3-carbinol (13C) to male rats markedly induced hepatic levels of CYP1A, and
dramatically down-regulated both the expression and activity of flavin-containing
monooxygenase (FMO) form 1 (Larsen and Williams, 1996).In this thesis, we
reported that there was no significant difference in hepatic FMO1 protein
expression in male guinea pigs, mice and rabbits after feeding 13C 2000 ppm for 4
weeks. However, CYP1A1/1A2 was induced in all three species fed 13C.
We have also demonstrated that alteration of the FMO/CYP ratio mediated
by 13C or DIM exhibited a marked shift in thein vitrometabolic profiles of drugs
or xenobiotics that are substrates for both monooxygenase systems primarily due to
the inhibition of FMO1 protein expression. The four compounds chosen in our
study, N,N-dimethylaniline, nicotine, tamoxifen and codeine were all tertiary
amines, typically excellent substrates for FMO, yielding the water soluble and
usually non-toxic N-oxide metabolites (Ziegler, 1993). The metabolism of N, N-
dimethylaniline, nicotine and tamoxifen was examined in liver microsomes of rats
fed 13C or DIM.All N-oxide formation of three compounds was decreased,
suggesting a potentialfor enhanced toxicity of three compoundsinvivo.
Additional studies are needed to examine whether human liver FMO3 responds to
dietary 13C and DIM as does rat liver FMO1.
After dietary administration for ten weeks of 13C or DIM to male rats, the
rats were gavaged with codeine, and analgesic response was determined using the120
tail flick assay. There was no difference between control and treated rats in the tail
flick assay due to highly variable response between rats. However, FMO1 protein
expression was significantlydecreased and CYP2D 1activitysignificantly
increased in rat liver microsomes pretreated with 13C or DIM, compared to control.
To investigate the effect of 13C or DIM on codeine metabolism, future studies
should increase the sample size per group and set up the instrument to reduce
experimental variation.
13C exhibits estrogenic activity in trout by inducing plasma vitellogenin, the
biomarker of estrogenic exposure.The estrogenic effects of 13C may be
responsible for promotion of aflatoxin B 1-initiated liver tumors in trout (Oganesian
et al.,1999).Our results also showed that 13C- and DIM- induced plasma
vitellogenin in a dose-dependent manner.In immature femalerats, both
compounds induced uterine peroxidase activity at doses lower than required for
CYP1A induction.
Overall, we have presented evidence that down-regulation of hepatic FMO 1
expression mediated by 13C is species-specific in rat.In vitro, dietary 13C and
DIM markedly shift the FMO/CYP ratio, suggesting that there could be an
alteration of the metabolism, and perhaps therapeutic and toxicological effects of
drugs andlor xenobiotics that are substrates for both monooxygenases in vivo. Both
compounds exhibit estrogenic activity in rainbow trout and immature female rat.
These results should be considered when assessing risk for the use of 13C and DIM
as chemopreventive agents or dietary supplements.121
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